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Characterization of the molecular interactions between Staphylococcus epidermidis biofilm infections 
and the host immune system 
 
ABSTRACT  
Staphylococcus epidermidis ranks first among the causative agents of nosocomial infections associated 
with indwelling medical devices. This association is due to the microorganism’s ability to colonize the 
surface of these devices and form biofilms. The biofilm lifecycle is divided into initial adhesion, 
accumulation and maturation, and biofilm disassembly. The major clinical complications of biofilm 
formation is their high resistance to antimicrobials and to the host immune system, resulting in the 
development of chronic infections. To uncover the mechanisms by which biofilms evade the host 
immune system and cause chronic infections, a transcriptomic analysis of S. epidermidis biofilms 
exposed to human blood was performed. Our results revealed extensive changes in the transcriptome, 
suggesting that a quick adaptation to the new environment was made. Genes involved in amino acids 
biosynthesis and iron utilization were strongly affected, indicating that these mechanisms are important 
factors in S. epidermidis biofilm survival in human blood. The biofilm disassembly stage has been 
associated with the development of acute infections, however, despite its importance in the clinical 
setting, it is the less studied of the biofilm lifecycle stages. Hence, to comprehend the interactions 
between biofilm disassembly and the host immune system, biofilm-released cells were characterized 
with reference to several virulence parameters. Our results revealed that S. epidermidis biofilm-released 
cells are unique in their phenotype and virulence potential, sharing some features with planktonic cells, 
but simultaneously displaying features similar to biofilm cells. The phenotypic differences were also 
manifested as differences in the S. epidermidis transcriptome in response to immune cells. Thus, 
targeting the particular properties of biofilm-released cells could be important to prevent the serious 
acute infections associated with biofilm dissemination. As a preventive measure, the ability of a 
monoclonal antibody raised against PNAG to inhibit S. epidermidis biofilm accumulation was tested. 
Interestingly, it was observed that depending on the strain, the antibody present variable effect 
resulting, in some cases, in the enhancement of biofilm accumulation in vitro. In conclusion, the work 
described throughout this thesis has given an important contribution to the knowledge of biofilms-
related infections, what will open new opportunities to effectively prevent the pathologic events 
associated with these serious and prevalent infections. 
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A caracterização das interações moleculares entre as infeções por biofilme de Staphylococcus 
epidermidis e o sistema imunitário do hospedeiro.  
 
RESUMO  
A espécie Staphylococcus epidermidis é atualmente considerada uma das principais causas do 
desenvolvimento de infeções nosocomiais, com particular associação a pacientes com dispositivos 
médicos invasivos. Esta associação é devida à capacidade desta bactéria aderir e formar biofilmes na 
superfície desses dispositivos. A formação do biofilme é classicamente dividida em adesão inicial, 
acumulação e maturação e, finalmente, a libertação de células do biofilme para o meio envolvente, num 
processo designado por dispersão. As grandes implicações clinicas da formação de biofilmes são a sua 
elevada tolerância aos agentes antimicrobianos e à resposta do sistema imunitário do hospedeiro, o que 
leva ao desenvolvimento de infeções crónicas. De forma a desvendar quais os mecanismos usados pela 
bactéria para escapar à resposta do sistema imunitário e causar infeções crónicas, foi caracterizado o 
transcriptoma de biofilmes de S. epidermidis cultivados na presença de sangue humano. Os resultados 
revelaram que a presença de sangue humano estimula uma extensa e rápida remodelação do 
transcriptome da bactéria, provavelmente para promover a adaptação ao novo e complexo ambiente 
envolvente. Os genes envolvidos na síntese de aminoácidos e na utilização de ferro sofreram as 
alterações mais pronunciadas, sugerindo que estes dois mecanismos são importantes fatores na 
sobrevivência da bactéria no sangue humano. Outra das etapas com grandes implicações clinicas é a 
dispersão de células do biofilme para o meio envolvente, uma vez que está diretamente associada ao 
desenvolvimento de infeções agudas importantes no hospedeiro. No entanto, esta é a etapa do ciclo de 
vida dos biofilmes de S. epidermidis menos bem compreendida. Assim, de forma a explorar as interações 
que ocorrem entre o sistema imunitário do hospedeiro e as células libertadas dos biofilmes de S. 
epidermidis, estas foram caracterizadas em diversos e importantes parâmetros envolvidos na sua 
virulência. Os nossos resultados revelaram que as células libertadas pelos biofilmes apresentam um 
fenótipo único, exibindo características particulares das células planctónicas, bem como das células 
derivadas do biofilme resultando também num estímulo particular do sistema imunitário do hospedeiro. 
Assim, estes resultados demonstram que um estudo mais aprofundado destas células poderá revelar 
novas oportunidades no desenvolvimento de estratégias preventivas contra as consequências 
patológicas associados à dispersão de células do biofilme. Numa perspetiva mais preventiva, a 
capacidade de um anticorpo monoclonal, específico para a PNAG, de inibir a acumulação dos biofilmes 
foi testada num sistema in vitro. Curiosamente, dependendo da estirpe testada, o anticorpo apresentou 
viii 
eficácia variável resultando, em alguns casos particulares, no aumento da capacidade da estirpe de 
formar biofilme.  
O trabalho descrito nesta tese contribuiu, significativamente, para aumentar o conhecimento sobre as 
infeções-associadas à formação de biofilmes e a interação destes com o sistema imunitário do 
hospedeiro. Este conhecimento irá, seguramente, abrir novas oportunidades para prevenir os eventos 
patológicos associados com estas infeções, por vezes severas, altamente prevalentes na sociedade.  
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General Introduction 
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I. Biofilms and human disease 
Traditionally bacteria have been regarded as individual organisms growing in homogenous planktonic, 
free-floating cultures [1,2]. In fact, for many centuries humans have suffered from acute bacterial 
infections caused by planktonic cells of specialized pathogens, which mounted life-threatening attacks 
[3]. However, in the last two decades it has been recognized that bacteria live preferentially in 
communities attached to a surface and surrounded by an extra-polymeric matrix mainly composed of 
polysaccharides, proteins, lipids and nucleic acids called biofilms [3-7]. Indeed, it is estimated that 99.9% 
of the bacterial communities occur in biofilms rather than in planktonic phenotypes [8], indicating that 
biofilm formation is an integral component of the prokaryotic lifecycle [9].  
In the clinical setting, biofilms are responsible for 65% of the of the infections treated in the developed 
world [10,11], being implicated in a variety of human diseases such as dental disease, endocarditis, 
urinary tract infections, cystic ﬁbrosis [12], and in several infections due to indwelling medical devices 
[13-15]. Biofilm formation on medical devices is characterized by the development of chronic and 
recalcitrant infections, which are less aggressive than acute infections, but persist for months or even 
years [10]. The chronicity of these infections are due to their complex 3-dimensional structures as well as 
their phenotypic heterogeneity [16-18], which promotes high resistance to antibiotic therapy [19,20] and 
to an attack from the host immune system effectors [21,22]. Hence, infections associated with biofilm 
formation on indwelling medical devices are hard to treat, often necessitating the removal of the 
infected device, increasing morbidity and ultimately contributing to increased patient mortality [23].  
 
Staphylococcus epidermidis biofilms and its clinical implications  
The genus Staphylococcus consists of non motile, non spore-forming, spherical and Gram-positive cocci, 
with sizes between 0.5-1.5 µm in diameter. They are facultative anaerobes that grow by aerobic 
respiration or by fermentation, and tolerate high concentrations of salt [24]. There are approximately 40 
different species within the genus Staphylococcus [25]. These species are commonly classified based on 
their ability to produce the enzyme coagulase. S. aureus is the most clinically significant among the 
coagulase-positive staphylococci, while S. epidermidis is the most clinically important species of all the 
coagulase-negative staphylococci (CoNS), representing up to 90% of the infections caused by CoNS 
[26,27].  
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CoNS typically reside on healthy skin and mucous membranes of humans and animals, rarely causing 
disease, and are most frequently encountered as contaminants of microbiological cultures [28]. 
However, in the last two decades, they have been increasingly recognized as a leading cause of several 
clinically relevant infections [29,30], with a particular association with the use of indwelling medical 
devices [31-33] (see Table 1.1 for more information).  
 
Table 1.1. S. epidermidis infections. Table adapted from [29].  
Infection/place of infection % of CoNS 
Infective endocarditis 11-17% 
Surgical site infections 13.7% 
Native valve Infective endocarditis  25% 
Cardiac implantable electronic devices 27% 
Bacteremia and intravascular catheter infections 30% 
Central venous catheters associated bloodstream infections  32.1% 
Central line associated bloodstream infections  34.1% 
Cebrospinal fluid shunts  37% 
Hip and knee replacement  36-77% 
 
This association is related to the strong ability of S. epidermidis to colonize the surface of indwelling 
medical devices and form biofilms [3], as well as to their ubiquity on healthy human skin [34] that greatly 
increases the risk of infection of the devices that penetrate skin [23,28]. Even though S. epidermidis 
biofilm infections rarely develop into life-threatening diseases, their high frequency and recalcitrant 
nature have important consequences on the patient’s quality of life, and are a significant burden to the 
public health system since the treatment of these infections often involves the physical removal of the 
infected devices [23].  
To be pathogenic, S. epidermidis elaborates several factors that contribute to its virulence, turning it into 
a successful pathogen in the context of biomaterial-associated infections [29]. The known virulence 
factors involved in S. epidermis pathogenesis are presented in the Table 1.2.  
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Table 1.2. Virulence factors presented by S. epidermidis. Table adapted from [23,35-37]. PNAG-poly-N-
acetylglucosamine; PGA-polyglutamic acid; AMP-antimicrobial peptides; CP-complement proteins.  
 
Virulence factor Gene/Operon Function 
Initial adhesion   
Autolysin adhesion aae Fibrinogen, fibronectin and vitronectin 
Autolysin atlE Binding to polystyrene and vitronectin 
Serine aspartate binding protein sdrF Binding to collagen 
Fibrinogen binding protein (fbe) sdrG Binding to fibrinogen 
Elastin binding protein ebp Binding to elastin 
Extracellular matrix binding protein embp Fibronectin binding 
Teichoic acids (cell wall) Multiple genes Binds to fibronectin 
Biofilm accumulation   
PNAG icaADBC Bacterial cell-cell interaction 
Biofilm-associated protein bhp Bacterial cell-cell interaction 
Accumulation-associated protein aap Bacterial aggregation after proteolysis 
Extracellular matrix binding protein embp Bacterial aggregation 
Immune evasion   
PNAG icaADBC Protects from AMPs, phagocytes, IgG and CP 
PGA capABCD Protects from AMPs and phagocytes 
Extracellular matrix binding protein embp Protects from phagocytes 
Resistance to AMPs    
SepA protease  sepA Involved in AMPs degradation 
AMP sensing system  apsRS Senses AMPS and resistance mechanisms 
Toxins   
Phenol soluble modulin psmδ  Pro-inflammatory cytolysin 
Exoenzymes   
Lipases GehC, GehD gehC, gehD Persistence on human skin 
Serine protease sspA Degradation of fibrinogen, CP; Tissue damage 
Cysteine protease sspB Tissue damage 
 
S. epidermidis biofilm lifecycle  
Due to its clear importance in human health and disease, the S. epidermidis biofilm lifecycle has been 
studied for years, and it is now described as a 3 stage process (Figure 1.1): I) initial adhesion, II) 
accumulation and maturation, and finally, III) biofilm disassembly [11,23,38].  
 
I. Initial adhesion  
The mechanisms and molecules involved in this step are directly dependent on the properties of the 
bacterial surface. In the case of abiotic surfaces, initial adhesion is mainly mediated by the 
physicochemical properties of both the bacteria and solid surface, as well as by the non-specific van der 
Waals, Lewis acid-base and electrostatic forces [39,40]. Nevertheless, there are some surface bacterial 
molecules that can play an important role at this stage due to their hydrophobic characteristics, such as 
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the autolysins AtlE [41] and Aae [42], accumulation associated protein (Aap) [43-46] and teichoic acids 
[47]. Conversely, in the case of biotic surfaces or abiotic surfaces coated with host matrix proteins, the 
initial adhesion is governed via specific, receptor-mediated interactions [48]. S. epidermidis expresses a 
large variety of surface-anchored proteins, collectively called microbial surface components recognizing 
adhesive matrix molecules (MSCRAMMs) [49]. These surface molecules bind specifically to host matrix 
proteins, allowing the attachment of the bacteria to the surface, and posterior biofilm formation. Since 
indwelling medical devices are readily coated with host matrix plasma proteins, these MSCRAMMs are 
fundamental for S. epidermidis biofilm formation on the surface of indwelling medical devices [41] and 
thus, S. epidermidis virulence.  
 
 
 
Figure 1.1. Schematic model of S. epidermidis biofilm lifecycle stages. Planktonic bacteria (1) will first adhere to a 
surface (2) followed by growth in clusters (3). With bacterial growth adhered to the surface, the matrix starts to be 
formed (4). Over time the biofilm becomes thicker and the matrix more prominent (5). Bacteria will then detach 
from the biofilm and will colonize other surfaces (6). Adapted from [50].  
 
II. Maturation 
After adhesion, bacteria start to divide and accumulate as multilayered cells in a process dependent on 
the synthesis of several extracellular and adhesive molecules, such as polysaccharides, proteins, lipids 
and nucleic acids, that will provide the framework into which bacterial cells are encased [4,51,52]. The 
production of the extracellular matrix is considered the hallmark of biofilm formation [3]. In this stage, 
the complex and typical tri-dimensionality of biofilms is achieved through a strong equilibrium between 
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both adhesive and disruptive forces that will allow the creation of channels for nutrients and waste 
circulation [53,54]. In order to form a cohesive structure, growing cells start to produce adhesive 
molecules that promote cell-cell inter-adhesion [23,38]. Unquestionably, poly-N-acetylglucosamine 
(PNAG), an exopolysaccharide, is the most important adhesive molecule for S. epidermidis biofilm 
formation [55], and for this reason it is also known as polysaccharide intercellular adhesin (PIA) [56]. This 
polysaccharide is synthesized by proteins encoded in the icaADBC operon, where IcaA and IcaD proteins 
produce a chain from activated N-acetylglucosamine monomers followed by its elongation and 
exportation to the cell surface, mediated by the IcaC protein [57]. Finally, N-acetylglucosamine 
monomers are partially de-acetylated by the cell-surface enzyme IcaB [58,59]. The acetylation process 
removes some of the N-acetyl groups from the polymer which confers the cationic character, that is 
essential to the attachment of the polymer to the bacterial surface [59]. Nevertheless, PNAG is not the 
only molecule involved in biofilm formation as several clinical isolates that lack the ica operon are able to 
form biofilms [60-62]. Recent studies have shown the involvement of surface proteins such as biofilm 
associated protein (Bap) [43,63,64], Aap [44] and extracellular matrix biofilm protein (Embp) [35] in 
biofilm formation. Additionally, teichoic acids, a characteristic component of the surface of Gram-
positive bacteria [65], as well as DNA resultant from lysed bacteria [66], have also been recognized as 
important adhesive molecules in S. epidermidis biofilms maturation due to their negative charge that 
allows the interaction with other surface molecules. Despite the adhesive molecules involved in this 
stage, disruptive forces are also needed in order to create viable biofilms which require the formation of 
channels through which nutrients can penetrate into deeper biofilm layers [67]. These factors can, 
ultimately, lead to the dispersion of cells in to the involving environment regulating, therefore, the 
thickness and the expansion of the biofilm [53].  
 
III. Disassembly 
Biofilm disassembly, or also termed dispersion, is the last stage of the biofilm lifecycle. Even though the 
benefits provided to bacteria through the biofilm mode of growth are evident, under some particular 
conditions, the biofilm lifestyle may no longer be advantageous, and therefore, in such cases, it is 
essential for some cells to leave the biofilm and assume the planktonic lifestyle [68]. Biofilm disassembly 
is believed to be a combination of complex, multi-factorial and highly regulated processes, that can be 
triggered by several external and/ or by bacterial-derived signals [69] (see Table 1.3). Nutrient 
availability, oxygen depletion, low levels of nitric oxide, changes in temperature, high or low levels of 
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iron, accumulation of wastes, the appearance of antimicrobial compounds or other threats are 
categorized as environmental cues [69]. On the other hand, acyl homoserine lactones, cell-cell 
autoinducing peptides (agr quorum sensing system), intracellular second messenger cyclic di-GMP, 
diffusible fatty acids and D-amino acids are signals produced by the bacteria themselves [54]. However, 
biofilm disassembly may also occur due to shear forces, abrasion or predator grazing [54], which are 
considered passive mechanisms, know as detachment. Under favorable conditions biofilms seem to 
continually release small amount of cells, however, it is thought that after large periods of growth they 
may undergo major disassembly events [70].  
 
Table 1.3. Biofilm maturation and disassembly determinants in Staphylococci. Table adapted from [38,68]. 
Effectors Mechanism/ Function Species 
PSMs   
PSMα-type Detergent like structure; disruption of the non covalent S. aureus 
PSM-type Detergent like structure; disruption of the non covalent S. aureus and S. epidermidis 
δ – toxin Detergent like structure; disruption of the non covalent S. aureus 
Proteases   
Dispersin B Degradation of the polysaccharides matrix S. epidermidis 
Lysostaphin Degradation of the polysaccharides matrix S. aureus and S. epidermidis 
Protease K Protease K, trypsin, Esp, V8 S. aureus and S. epidermidis 
Nucleases   
DNase I Degradation of extracellular DNA S. aureus and S. epidermidis 
Nuc1 Digestion of DNA-based bioﬁlm matrix S. aureus 
Nuc2 Digestion of DNA-based bioﬁlm matrix S. aureus 
Regulators   
CidA Control of autolytic activity, eDNA release S. aureus 
LrgAB Inhibitor of CidA-mediated lysis S. aureus and S. epidermidis 
SarA Control of proteases S. aureus and S. epidermidis 
Agr Control of PSMs and proteases S. aureus and S. epidermidis 
Others   
pH Reactivation/ inactivation of agr regulatory system S. aureus and S. epidermidis 
 
Despite all the signals that can trigger biofilm dispersion, bacterial cells within the biofilm are enclosed in 
the matrix that needs to be dissolved by effector molecules to allow the release of the cells into the 
surrounding environment [71]. These effector molecules include surfactants such as phenol soluble 
modulins (PSM) [71], polysaccharide degrading enzymes [72,73], proteases [71,74,75], nucleases [76,77] 
and also bacteriophages [4,78] (for more detail see Table 1.3). The release of the cells from the biofilm 
into the involving environment has been implicated in the development of several serious infections 
such as bacteremia [79], embolic events of endocarditis [80] and pneumonia [81] contributing, 
therefore, to the pathogenicity of S. epidermidis biofilms infections.  
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II. S. epidermidis biofilms interaction with the host immune system  
The infections caused by bacteria upon entering the human body can be divided into acute and chronic. 
This classification usually reflects differences in the lifestyle of the bacteria that are causing the infection 
[82]. Frequently, acute infections involve planktonic bacteria, which cause severe clinical symptoms but 
that can, generally, be prevented or treated efficiently with the use of vaccines, antibiotics and infection 
control measures [83,84]. On the other hand, chronic infections are typically developed in the presence 
of bacterial biofilms [82,83] and are characterized by slow progression and low grade symptoms [83]. 
These infections are very difficult, if not impossible to treat with current therapies, because bacteria 
within biofilms have shown incredible tolerance to antibiotics [85] and to the potent host innate and 
adaptive immune effectors [86-88]. Although the nature of the antibiotic resistance have been explored 
for years, much less is known about the mechanisms employed by S. epidermidis biofilms to evade the 
host immune system.  
 
Immune system: an overview 
The function of the immune system is to protect the host against microbial infections. The development 
of an infectious disease involves complex interactions between the microbe and the host. The key events 
during infection development include: 1) entry of the microbe, 2) invasion and colonization of the host 
tissues, and 3) tissue injury [89]. In order to control the key events of infection, the host immune system 
present two types of immune responses: innate and adaptive. The major difference between these 2 
types of responses is that the adaptive immune response is highly specific for the pathogen and 
improves with each encounter with the same antigen, while innate immunity consists of mechanism that 
exist before infection, and do not improve even after a repeated encounter with the same antigen [90] 
(see Table 1.4 for more detail). Therefore, the defense against microbes is mediated by the early 
reactions of the innate immune system and the later responses of adaptive immunity. 
 
Innate immunity 
The principal components of the innate immunity are the physical and chemical barriers, such as 
epithelia and antimicrobial substances produced at epithelial surfaces, phagocytic cells (neutrophils and 
macrophages), natural killer cells, blood proteins, including members of the complement system and 
other mediators of inflammation, such as cytokines [90]. Each of these cells and proteins play a different 
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role in the response to microbes. In brief, neutrophils, mononuclear phagocytes and natural killer cells 
attack microbes that have breached the epithelial barriers and entered into tissues or the circulation. 
Macrophages and natural killer cells, secrete cytokines, which in turn activate phagocytes and stimulate 
the cellular reaction of the innate immunity, the inflammation. If microbes enter the circulation, they are 
attacked by various plasma proteins, the complement system being the major circulating protein cascade 
of the innate immunity [92].  
 
Table 1.4. Principal distinctive features between innate and adaptive immunity together with their specific 
components. Table adapted from [91]. NK-natural killer; AMPs-antimicrobial peptides.  
 Innate Adaptive 
Features   
Specificity Pathogen-associated molecular patters  For antigens of microbes 
Diversity Limited Very large 
Memory None Yes 
Response time Immediately Days 
Components   
Physical /chemical barriers Skin, mucosal epithelia AMPs 
Lymphocytes and antibodies 
at epithelial surfaces 
Blood proteins Complement Antibodies 
Cells Macrophages, neutrophils, NK cells Lymphocytes B and T 
 
Adaptive immunity 
Innate and adaptive immunity are in constant interaction where the cells and factors of each component 
work cooperatively. The innate immune reactions against microbes stimulates adaptive immune 
responses and influences the nature of the adaptive responses. On the other hand, adaptive immune 
responses use many of the innate effectors to eliminate microbes [91]. Adaptive immune responses are 
divided into 2 types: humoral and cell-mediated immunity, which are facilitated by different components 
of the immune system and function to eliminate different types of microbes [91] Humoral immunity is 
mediated by antibodies produced by B lymphocytes activated by specific antigen exposure and 
maturation into plasma cells. Antibodies bind proteins and polysaccharides from the bacterial cell wall 
and also bacterial toxins [90]. Antibodies also function as molecular tags since they mark antigens for 
destruction; bacteria covered with antibodies are readily ingested by phagocytes or destroyed by 
complement proteins present in the blood [91]. However, antibodies are not effective against pathogens 
that are present inside the cells, hence in these particular cases cell-mediated immunity takes place, 
which is mainly governed by T lymphocytes [90]. 
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S. epidermidis immune evasion  
Contrary to what was previously thought, biofilms can actually engage the host immune system as well 
as their planktonic counterparts do [83]. However, the efficiency of the immune response in eliminating 
infecting microbial cells is impaired in biofilms [3]. One of the first hypothesis to explain the impairment 
of the immune effectors in biofilms was the physical barrier posed by the matrix [93]. However it was 
shown that leukocytes were able not only to penetrate the biofilm structure but also phagocytose the 
bacteria within the biofilms [22,94]. Therefore, several studies were performed in order to unravel the 
mechanisms and/or molecules involved in biofilm evasion. Besides its clear importance in biofilm 
accumulation, PNAG is also involved in S. epidermidis biofilm immune evasion [95-97]. Due to its positive 
charge [57], PNAG protects biofilm cells against the action of the cationic AMPs through electrostatic 
repulsions [58,98]. Interestingly, it also protects against anionic AMP by sequestering these molecules in 
a similar way that alginate protects against tobramycin in Pseudomonas aeruginosa [99]. In addition, it 
was shown that PNAG-producing S. epidermidis strains are more resistant to phagocytosis by neutrophils 
[58,97] and macrophages [100], than isogenic ica-negative mutants, probably due to the ability of PNAG 
to decrease the deposition of both antibodies and components of the complement system proteins onto 
the bacterial surface [96]. In addition, PNAG purified from S. aureus was shown to induce the production 
of antibodies to PNAG [101-103], which were able to confer protection [104-106] and to diffuse 
efficiently into deeper layers of S. epidermidis biofilms [86].  
Another protective exopolymer involved in immune evasion is the extracellular anionic polymer poly-γ-
DL-glutamic acid (PGA). This molecule that was first described in Bacillus anthracis [107] and is encoded 
by the cap locus that was found to be more expressed when cells are in the biofilm phenotype [108]. 
Similar to PNAG, PGA has an important role in the protection of S. epidermidis against the innate host 
defense. It was shown that PGA decreased the efficacy of phagocytic process as well as AMPs action, 
contributing therefore, for S. epidermidis biofilms pathogenicity [109]. In addition to these expolymers, 
an antimicrobial peptide sensing system (aps) was found in S. epidermidis which is crucial for S. 
epidermidis immune evasion [110]. The aps system senses the presence of AMPs produced by the host 
and up-regulates AMP-defensive mechanisms such as d-alanylation of teichoic acids [111,112] and the 
lysinylation of phospholipids by the MprF enzyme [113], which will decrease the anionic charge of the 
bacterial surface and prevent the binding of the cationic AMPs [110]. Furthermore, the VraF and VraG 
proteins possibly function as an exporter that removes AMPs from the bacterial cytoplasmic membrane 
[114]. In addition to the mechanisms controlled by the aps system, the production of proteases such as 
SepA also play an important role in degradation of the AMPs that reside inside neutrophils that are used 
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to kill bacteria upon phagocytosis [115]. Thus, SepA is important for S. epidermidis immune evasion [87]. 
Recently it was shown that S. epidermidis produces the PSMδ that displays potent cytolytic activity 
against neutrophils being, therefore, one more mechanism to subvert the host immune system [87]. 
The role of the specific, adaptive immune response to S. epidermidis infection is less well understood and 
the knowledge very scarce. The fact that our immune system has difficulties clearing long lasting S. 
epidermidis infections, despite the production of antibodies against S. epidermidis proteins, indicates 
that the adaptive host defense system might not be efficient against S. epidermidis [23]. However more 
studies are needed to better understand the nature of S. epidermidis resilience to the potent host 
immune responses.  
 
 
III. AIMS AND OBJECTIVES 
Due to the debilitating nature and economic impact of S. epidermidis biofilm infections, preventing or 
treating these infections is of paramount significance in modern medicine. Hence, it is essential that we 
understand the mechanisms whereby S. epidermidis evades the host immune system. Therefore, this 
thesis has as its primary objectives:  
I. The study of the interaction between S. epidermidis biofilms and human blood-circulating 
immune cells and soluble factors; 
II. The characterization of the phenotypic traits and interaction of the S. epidermidis biofilm-
released cells with the host immune system using in vitro and in vivo models. 
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CHAPTER 2.  
 
Optimizing a qPCR gene expression quantification 
assay for S. epidermidis biofilms 
 
 
 
ABSTRACT  
Biofilm gene expression analysis by quantitative PCR has been increasingly 
used to understand the role of biofilm formation in the pathogenesis of S. 
epidermidis infections. However, depending on the RNA extraction procedure, 
cDNA synthesis kit and qPCR master mixes used, gene expression 
quantification can be suboptimal. Due to biofilm composition, in particular the 
presence of the extracellular matrix, some RNA extraction kits are not suitable 
for S. epidermidis biofilms. In this chapter, we describe a custom RNA 
extraction assay followed by the evaluation of gene expression using different 
commercial reverse transcriptase kits and qPCR master mixes. Our custom RNA 
extraction assay was able to produce good quality RNA with reproducible gene 
expression quantification, reducing the time and the costs associated. We also 
tested the effect of reducing cDNA and qPCR reaction volumes and, in most of 
the cases tested, no significant differences were found. Finally, we titered SYBR 
Green I concentrations in standard PCR master mixes and compared the 
normalized expression of the genes icaA, bhp, aap, psm and agrB using 4 
distinct biofilm forming S. epidermidis strains to the results obtained with 
commercially available kits. The overall results demonstrated that despite 
some statistically differences detected, the customized qPCR protocol resulted 
in the same gene expression trend presented by the high standards 
commercially available kits used. 
 
 
 
The work presented in this chapter was published in PLoS One 
2012;7(5):e37480. 
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BACKGROUND  
The study of gene expression is of one of the most important tools used to unravel the biological 
processes occurring in an organism under a particular condition [1]. Gene expression has proved to 
be a useful tool to the validation, for instance, of the transcriptional measurements associated with 
the shift of S. epidermidis to the mode of infection [2-4]. Advances in molecular biology and 
bioinstrumentation have led to the development of several new techniques with a range of 
sensitivities, throughputs and quantitative capabilities [1] such quantitative PCR (qPCR), microarrays 
and RNA sequencing analysis, that allows to analyze gene expression. Although qPCR is used for the 
analysis of a restricted number of genes, is still widely used due to the easiness, versatility and 
availability of the systems used for such analysis. Additionally, due to its high sensitivity, qPCR is the 
technique of choice for microarrays or RNA sequencing results validation [5,6]. Nonetheless, the 
success of the existing or any emergent RNA-based analysis relies on the quality of the messenger 
(m) RNA, since its purity and integrity can impact the accuracy of subsequent analytic techniques 
[7,8]. Currently, there are several commercially available kits for RNA extraction, however, most of 
these kits were not tested in biofilm cultures, and depending on the principle and properties applied 
by each kit, the quantification of mRNA transcripts can be impaired [9,10]. Additionally, it has been 
shown that different cDNA synthesis kits and gene expression quantification detection systems for 
qPCR can also be a source of variation that can largely impair gene expression quantification [11]. 
Hence, in this chapter, we describe the comparison of different commercially available kits and, 
simultaneously, the development of a customized protocol for gene expression quantification for 
qPCR, using S. epidermidis biofilm as samples. The custom protocol was optimized to maximize 
reliability of results, reduce time, and minimize the costs involved. 
 
 
MATERIALS AND METHODS  
Bacterial strains and growth conditions 
For this study the following S. epidermidis biofilm-forming strains were used: 9142, LE7, IE186 and 
M129 [12]. Biofilms were formed as previously optimized [13]. In brief, a single colony of each S. 
epidermidis strains used was inoculated into Tryptic Soy Broth (TSB) (Oxoid, Cambridge, UK) and 
incubated at 37 °C and 120 rpm overnight. Afterwards, 1:100 dilution of the overnight culture was 
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performed in 1 mL of fresh TSB supplemented with 1% (w/v) of glucose (Fisher Scientific, MA, USA) to 
induce biofilm formation, and placed into 24-well plate (Orange Scientific, Braine-l'Alleud, Belgium). 
The plates were then incubated at 37oC and 120 rpm for 24 ± 2 hours. Prior to any analysis, biofilm 
supernatants were removed, biofilms washed once and suspended in 1 mL of 0.9% NaCl. Planktonic 
bacteria were grown in 2 mL TSB in 15 mL tubes at 37 °C and 120 rpm for 18 ± 1 hours. 
 
RNA extraction with commercially available kits 
For RNA extraction we have selected two commercially available kits, previously tested by our 
research group [9], which applies distinct principles: 1) Fast RNA® Pro Blue (MP Biomedicals, CA, 
USA), that uses mechanical and chemical lyses along with organic purification, and 2) PureLinkTM RNA 
Mini Kit (Invitrogen, CA, USA), which employs enzymatic lyses together with silica-membrane based 
purification. The procedures were performed as recommended by the manufacturers with a 
particular improvement: the enzymatic lyses was performed using 15 mg/mL of lysozyme (Sigma, 
MO, USA) for 60 min at 37 oC. This optimization increased the yield of total RNA for the double.  
 
Customized RNA extraction protocol 
The custom protocol described here was devised based on the efficacy of the mechanical and 
chemical lyses together (glass beads combined with phenol), and the easiness and quickness of the 
silica-membrane purification (ISOLATE RNA Mini Kit columns system). In brief, bacterial pellets were 
suspended in 100 µL RNase-free water and transferred into a 2 mL safe lock tube containing 0.4 g of 
acid-washed 150-212 mm silica beads (Sigma), 400 µL lyses buffer R (provided by the kit) and 500 µL 
90% phenol solution (AppliChem, Darmstadt, Germany). This mixture was vortexed for 20 seconds. 
Thereafter, bacterial cell lyses was performed using a FastPrep® cell disruptor (BIO 101, Thermo 
Electron Corporation, Thermo Scientific, MA, USA) at a 6.5 meter/second during 35 seconds. The 
samples were then cooled on ice for 5 minutes and the lyses cycle repeated twice. Afterwards, 
samples were centrifuged at 16000 g for 5 minutes, and supernatants transferred into a new tube 
and mixed with equal volume of 100% ethanol (Fisher Scientific). From here all steps were done at 
room temperature except where otherwise noticed. The samples (including any remaining 
precipitate) were transferred into the ISOLATE RNA Mini kit column system (Bioline, London, UK) and 
centrifuged at 12000 g for 15 seconds. The flow-through was discarded and each column washed 
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with 700 µL of wash buffer I and centrifuged at 12000 g for 15 seconds. The flow-through was 
discarded and the column inserted into the same collection tube. Thereafter, 500 µL of wash buffer II 
was added to each column and centrifuged at 12000 g for 15 seconds. The flow-through was 
discarded and the columns reinsert into a new collection tube for a new centrifugation at 12000 g for 
2 minutes in order to remove any trace of ethanol. The collection tube was discarded and each 
column was inserted into a recovery tube. Finally, RNA was eluted by adding 45 µL of RNase-free 
water to the center of the membrane, incubated for 1 minute and centrifuged for 1 minute at 12000 
g.  
 
DNase treatment  
In order to degrade any possible genomic DNA co-purified with total RNA, the samples were treated 
with DNase I kit (Fermentas, Vilnius, Lithuania). Briefly, 2 µL of DNase I and 5 µL of reaction buffer 
were added to the RNA samples and incubated at 37 oC for 30 minutes. Subsequently, 5 µL of 25 mM 
EDTA was added, and the DNase I enzyme inactivated by heating the samples at 65 oC during 10 
minutes.  
 
RNA quality determination 
The concentration and purity of the total RNA was spectrometrically determined using a NanoDrop 
1000TM (Thermo Scientific). The absorbance ratio A260/A280 was used as an indicator of protein 
contamination, and A260/A230 as an indicator of polysaccharide, phenol, and/or chaotropic salts 
contamination [14]. The integrity of the total RNA was assessed by visualization of the 23S/16S rRNA 
banding pattern. Electrophoresis was carried out at 80 Volts for 60 minutes using a 1.5% agarose gel. 
The gel was stained with ethidium bromide (Fisher Scientific) and visualized using a GelDoc2000 (Bio-
Rad, Hercules, CA, USA). RNA was stored at -80 oC until further use.  
 
Complementary DNA synthesis 
Complementary DNA (cDNA) synthesis was performed using 4 different available commercial kits: 1) 
Super Script® VILOTM (Invitrogen), 2) RevertAaidTM First Strand cDNA Synthesis kit (Fermentas), 3) 
iScriptTM cDNA synthesis (Bio-Rad) and 4) qScriptTM cDNA Synthesis (Quanta BioSciences, MD, USA), 
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following the manufacturer’s instructions. The same amount of total RNA (500 ng/20 µL) was reverse 
transcribed using two reaction volumes: 20 µL, as described by the manufacturer, or 10 µL. Genomic 
DNA carry-over was determined by performing a control that lacks the reverse transcriptase enzyme 
(no-RT control). All RNA extracted was absent of significant genomic DNA, as determined by an 
average cycle threshold difference of 18.5 ± 3.5, equivalent to a maximum quantification error of 
0.0003%. 
 
Gene expression quantification by qPCR 
Oligonucleotide primers for the detection of 16S rRNA, icaA, aap, bhp, agrB and psm were designed 
using the Primer3 software [15] having, respectively, either S. epidermidis RP62A (PubMed accession 
number NC_002976.3) or ATCC12228 (PubMed accession number NC_004461.1) genome as 
template (Table 2.1).  
 
Table 2.1. Oligonucleotide primer sequences used for qPCR analysis. FW-forward; RV-reverse; bp-base pair 
Target gene  
Oligonucleotide primers sequence  
(5’ to 3’) 
TM (oC) 
Amplicon size 
(bp) 
16S 
FW GGGCTACACACGTGCTACAA 59.79 
176 
RV GTACAAGACCCGGGAACGTA 59.85 
icaA 
FW TGCACTCAATGAGGGAATCA 60.20 
134 
RV TAACTGCGCCTAATTTTGGATT 59.99 
aap 
FW GCACCAGCTGTTGTTGTACC 59.22 
190 
RV GCATGCCTGCTGATAGTTCA 59.98 
bhp 
FW TGGACTCGTAGCTTCGTCCT 60.01 
213 
RV TCTGCAGATACCCAGACAACC 60.13 
agrB 
FW AATTCGTTTAGGGATGCAGGT 59.85 
142 
RV ACCGTGTGCATGTCTCCTAAT 59.49 
psm 
FW AGCAGAAGCTATTGCAAATACAG 57.96 
105 
RV CCTAATACGCTAACGCCACTTT 59.72 
 
qPCR analysis was performed using 4 different commercial qPCR mixes: 1) mi-real-time EvaGreen® 
Master (Metabion, Martinsried, Germany), 2) Maxima® SYBR Green Master Mix (Fermentas), 3) iQTM 
SYBR® Green Supermix (Bio-Rad) and 4) PerfeCTa® SYBR® Green SuperMix (Quanta BioSciences), and 
also by using 3 standard PCR kits based on Taq polymerase, that were mixed with concentrated SYBR 
Green I (Invitrogen) for transcripts detection: 1) DyNAzymeTM II PCR Master Mix (Finnzymes, Vantaa, 
Finland), 2) MyTaq PCR mix (Bioline, London, UK) or 3) EzWay Direct Taq PCR MasterMix (Koma 
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Biotech, Seoul, South Korea). Different concentrations of SYBR Green I, ranging from 3.2x to 0.1x, 
were used. Two qPCR reaction volumes were also tested: 20 and 10 µL. The 20 µL reactions 
contained 2 μL diluted cDNA or no-RT control, 10 pmol of each primer, 6 μL nuclease free H2O, and 
10 μL of the respective 2x master mix. The 10 µL reactions contained half the respective volumes. 
Primer efficiencies were determined by the dilution method as well as performing a temperature 
gradient reaction from 50 to 65oC [9]. At 60oC, both set of primers had the best and more similar 
efficiencies values. qPCR run was performed on a CFXTM 96 (Bio-Rad) with the following cycle 
parameter: 95oC for 30 seconds, 39 cycles of 95oC for 5 seconds, 60oC for 15 seconds and 68oC for 15 
seconds. qPCR products were analyzed by melting curves for unspecific products or primer dimer 
formation. Relative fold increase of specific mRNA transcripts in biofilms comparing with planktonic 
cultures, was calculated using 2ΔCt method, a variation of the Livak method, where 2 stands for the 
100% reaction efficiency (the reaction efficiency was determined experimentally and thus 100% 
efficiency was replace by the real efficiency) and ΔCt = Ct (housekeeping gene)-Ct (target gene). The 
data analysis was based on at least 3 independent experiments. 
 
Statistical analysis 
All the assays were compared using one-way analysis of variance (ANOVA) by applying Levene’s test 
of homogeneity of variances and Tukey’s multiple comparisons test, and also the paired sample t-
test, using SPSS. Student’s t-test was applied to all experimental data for rejection of some 
experimental values. All tests were performed with a confidence level of 95%. 
 
 
RESULTS 
RNA extraction and quality assessment 
Two commercially available RNA extraction kits with distinct principles were selected: FastRNA® Pro 
Blue, which uses mechanical and chemical lyses together with organic extraction, and PureLinkTM 
RNA Mini Kit, which uses enzymatic lyses and silica-based membrane extraction. We then combined 
the best features of both kits, namely the high yield resulting from the glass beads- and phenol-based 
lyses and the fast isolation protocol provided by the columns system [9]. For the custom extraction, 
we tested 4 different column-based isolation kits. As illustrated by the results in Table 2.2, the 
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PureLinkTM kit yielded very low concentration of RNA. However, when PureLinkTM column system was 
combined with the custom lyses, we were able to recover 26-fold more RNA, obtaining very similar 
values as that obtained when using the Fast RNA® Pro Blue kit.  
 
Table 2.2. Comparison of RNA yield and purity obtained by the different RNA extraction procedures used. 
Twenty-four hours biofilms were disrupted and RNA extraction performed using commercially available kits or 
an optimized custom procedure. The values represent the mean plus or minus the standard deviation of 3 
independent experiments. Statistical differences between custom and commercial kits were analyzed with 
paired t-test. **p<0.01 
 
 
 
 
 
 
While all RNA extraction procedures resulted in acceptable low levels of protein contamination 
(A260/A280>1.8), some of the kits presented an A260/A230 below 1.8. Total RNA integrity was assessed 
by visualization of the 23S/16S rRNA banding pattern. As can be seen in the Figure 2.1, the RNA 
extracted using the different procedures was intact since no smear was detected. No integrity 
information was assessed for the RNA extracted with PureLinkTM RNA Mini Kit, as the low yield was 
below the limit of detection of our image system.  
 
 
 
 
 
 
 
 
RNA extraction kit 
RNA yield 
(ng/µL) 
A260/A280 
ratio 
A260/A230 
ratio 
FastRNA® 499±74 2.2±0.0 2.1±0.1** 
PureLinkTM 17±3** 2.0±0.1 1.4±0.2** 
Custom RNA w/ PureLinkTM 453±49 2.0±0.1 1.4±0.6** 
Custom RNA w/ FavorPrepTM    226±31**    1.8±0.1** 1.8±0.2** 
Custom RNA w/Direct-zolTM   182±5** 2.1±0.1 2.2±0,2** 
Custom RNA w/ISOLATE RNA mini kit  422±84 1.9±0.1 1.6±0.1** 
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Figure 2.1. RNA integrity determined by visualization in ethidium 
bromide stained agarose gel. Ldd-DNA ladder (23 Kbp), C1-
Custom with PureLinkTM Mini Kit; C2-Custom with FavorPrepTM 
Blood/cultured cell total RNA; C3-Custom with Direct-zol
TM 
RNA 
MiniPrep; C4-Custom with ISOLATE RNA Mini kit; PL-PureLinkTM; 
PB-FastRNA® Pro Blue. 
 
 
cDNA kits and qPCR master mixes influence in gene expression quantification  
In qPCR a common and important optimization step is the determination of the optimal cDNA 
dilution that should be used in order to obtain reproducible and meaningful results. Undiluted cDNA 
can interfere with the PCR reaction and thus, several cDNA dilutions were tested by determining the 
icaA gene fold increase in biofilms samples (Figure 2.2).  
 
 
Figure 2.2. Effect of cDNA dilution in icaA gene expression quantification. cDNA synthesized from biofilms and 
planktonic cultures of S. epidermidis strain 9142 was diluted from 1:10 to 1:1000 fold and icaA transcripts 
quantified by qPCR. cDNA replicates were synthesized using the same RNA sample but independent cDNA 
synthesis reactions. The values represent the mean plus or minus standard error of the mean of 3 independent 
experiments. Statistical differences were analyzed with one-way ANOVA and Tukey’s multiple comparison test. 
*p<0.05.  
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The lowest dilution common to all the 4 tested kits that shown reliable results, as assessed by no 
significant variation between the tested cDNA concentrations, was the 1:100 dilution. Therefore, for 
all the further studies cDNA was diluted 100-fold. As different RNA extraction kits resulted in variable 
RNA quality, we also sought to determine whether the cDNA synthesis and qPCR kits would have 
similar variability. Therefore, several cDNA kits and qPCR master mixes commercially available were 
tested. Using the cDNA synthesized by different kits, icaA gene expression was quantified using 
different master mixes. Interestingly, as illustrated in Figure 2.3, significant differences were found in 
icaA quantification when varying the cDNA kit (p<0.05, ANOVA), but not when varying the qPCR 
master mix (p>0.05, ANOVA) demonstrating that, besides RNA extraction procedure, the selection of 
the cDNA synthesis kit will also impact gene expression quantification. Despite the consistent icaA 
gene expression determination with different qPCR kits, the PCR efficiency varied somewhat 
between 84 ± 4% for iQTM SYBR® Green, 84 ± 7% for Maxima ® SYBR Green 78 ± 5% for PerfeCTa® 
SYBR® Green and 87 ± 6% for mi-real time EvaGreen® master mixes. The efficiency of PerfeCTa® 
SYBR® Green was significantly different from the efficiency of mi-real-time EvaGreen® Master mix 
(p<0.05, ANOVA), however no important consequences on gene expression quantification were 
observed. 
 
 
Figure 2.3. The impact of different cDNA and qPCR commercial kits in icaA gene expression quantification. 
cDNA (1:100) from biofilms and planktonic cultures of S. epidermidis strain 9142 was synthesized using 
different kits. The impact of different qPCR master mixes in icaA quantification was also tested. The values 
represent the mean plus or minus standard error of the mean of 3 independent experiments. Statistical 
differences between cDNA kits (*) or qPCR master mixes () were analyzed with ANOVA and Tukey’s multiple 
comparison test. */ p<0.05. 
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Reduction of the reverse transcriptase and qPCR volume reaction are among the possible ways to 
reduce costs associated with gene expression analysis. To determine if a lower volume of reaction 
could still provide consistent and reproducible results, reverse transcriptase reactions were 
performed using either 10 or 20 µL of volume, and quantified with 20 µL volume reaction of 
Maxima® SYBR Green Master Mix. Simultaneously, cDNA obtained from a 20 µL reaction with 
RevertAidTM First strand cDNA synthesis kit was quantified using either 10 or 20 µL of qPCR reaction 
volume. As shown in Figure 2.4, the variation of qPCR volume did not affect the quantification of icaA 
gene expression (p>0.05, paired sample t-test). The same was not true for the reverse transcriptase 
reactions, since significant variation was found, particularly, in the cDNA obtained using SuperScript® 
VILOTM cDNA synthesis kit (Figure 2.5).  
 
 
Figure 2.4. Variation in icaA gene expression quantification using different qPCR reaction volumes. cDNA 
from biofilms and planktonic cultures synthesized using RevertAidTM First Strand cDNA synthesis kit (20 µL 
reaction) was used for icaA transcripts quantification by different qPCR master mixes and using different 
reaction volumes. The values represent the mean plus or minus standard error of the mean of 3 independent 
experiments. Statistical differences between 10 µL and 20 µL reactions were analyzed with paired t-test.  
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Figure 2.5. Variation in icaA gene expression quantification using different cDNA. cDNA from biofilms and 
planktonic cultures synthesized using 20 µL or 10 µL reaction volumes, was used for icaA transcripts 
quantification. The transcripts were detected using Maxima® SYBR Green Master Mix. The values represent the 
mean plus or minus standard error of the mean of 3 independent experiments. Statistical differences between 
10 µL and 20 µL reactions were analyzed with paired t-test. *p<0.05.  
 
Optimization and validation of a custom qPCR reaction for S. epidermidis biofilm gene expression 
Another way to reduce costs associated with gene expression analysis by qPCR is to prepare a 
custom SYBR Green qPCR mix. This can be achieved by using a common PCR mix (or the individual 
components of the mix, namely Taq polymerase + dNTPs + buffers) and adding the fluorescent dye. 
This approach requires several optimization steps, since SYBR Green I concentration can interfere 
with the PCR reaction [16,17]. Using a 10000× solution of SYBR Green I (Invitrogen, NY, USA) different 
PCR mixes were titrated, ranging in final concentrations of SYBR Green I from 4× to 0.5×. As 
expected, SYBR Green I concentration strongly influenced the relative fluorescence units (RFU) 
detected in each reaction (Figure 2.6).  
Generally, the higher the concentration, the higher the RFU detected. However, in the custom mixes 
based on DyNAzymeTM II PCR Master Mix and MyTaqTM PCR, SYBR Green I concentrated 4 × resulted 
in no RFU detection. To determine if this absence of RFU was result of any signal interference with 
the fluorescence detector or a PCR reaction inhibition, the products of the qPCR were run on a 1.5% 
agarose gel (Figure 2.7). 
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Figure 2.6. SYBR Green I dilution influence in qPCR assay using different Taq polymerase PCR kits. The tested 
SYBR Green I concentrations ranged from 0.5 to 4× using the following commercially available PCR kits: Ezyway 
Direct  PCR Mix (A), MyTaq PCR mix (B) and DyNAzymeTM II PCR Master Mix (C). The data presented are 
representative of two independent experiments. 
 
It was observed that the absence of RFU in the qPCR mix with 4× SYBR Green I was the result of an 
inhibition of the PCR reaction. To validate the custom qPCR mix, we selected the DyNAzymeTM II PCR 
Master Mix supplemented with 1x SYBR Green I, and compared the outcome of gene expression to 
that obtained using Maxima ® SYBR Green Master Mix. We selected a set of genes that are known to 
be involved in biofilm formation and accumulation, namely bhp, icaA, and aap [18,19], and also some 
genes involved in biofilm modulation, such as agr and psm [2]. 
 
 
 
 
Figure 2.7. Effect of SYBR Green I concentration in the inhibition of 
the qPCR. The qPCR was performed using the DyNAzyme
TM
 II PCR 
Master Mix. 
 
RNA was extracted from biofilm and planktonic cultures from four distinct S. epidermidis strains, that 
were previously characterized in terms of biofilm formation [12]. The cDNA used for the validation of 
the custom qPCR mix was synthesized with RevertAidTM First Strand cDNA synthesis kit in a 20 µL 
reaction volume. No significant differences were found in the PCR efficiency when using either 
custom or commercial mixes (88 ± 7% for the custom assay). Additionally, the results obtained with 
A B C 
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the custom qPCR were consistent with the results obtained with the commercial Maxima® SYBR 
Green Master Mix, being either up- or down-regulated genes detected in similar quantities (Table 
2.3). Nevertheless, statistically significant differences were found in 5 of the 20 comparisons (16, if 
excluded the genes that were not detected) (p<0.05, paired-samples t-test). 
 
Table 2.3. Comparison of gene expression quantification using a custom qPCR mix and Maxima® SYBR Green 
Master Mix. cDNA from biofilms and planktonic cultures was synthesized using a 20 µL reaction iScriptTM cDNA 
synthesis kit, and quantified in a 10 µL qPCR reaction using Maxima® SYBR Green Master Mix or custom made 
master mix. Values represent the fold difference between biofilm and planktonic population plus or minus 
standard deviation of 3 independent experiments. Values above 1 indicate up-regulation in biofilm, and below 
1 indicates down-regulation. Statistical differences between custom and Maxima® SYBR Green Master Mix 
reactions were analyzed by paired-sample t-test. * p<0.05. ND-not detected. 
 
 S. epidermidis strains 
9142 IE186 M129 LE7 
icaA 
Custom 8.31±3.39* 41.12±17.50 45.63±21.14 6.40±2.42 
Maxima® 12.87±2.51* 56.89±22.11 71.53±59.28 5.50±3.33 
bhp 
Custom 5.43±0.82* 2.02±1.31 ND ND 
Maxima® 7.02±1.11* 2.33±2.00 ND ND 
aap 
Custom 1.62±0.20* 2.80±2.34 5.81±1.04* 3.47±0.74* 
Maxima® 2.14±0.32* 2.10±0.77 8.49±2.12* 5.57±0.61* 
psmβ 
Custom 1.46±0.64 0.35±0.20 0.19±0.14 0.48±0.34 
Maxima® 1.13±0.39 0.35±0.07 0.21±0.11 0.31±0.11 
agrB 
Custom 1.31±0.26 0.42±0.24 0.99±0.94 0.60±0.36 
Maxima® 1.06±0.47 0.68±0.26 0.77±0.09 0.77±0.09 
 
 
DISCUSSION 
The aim of this study was to optimize the gene transcript quantification of S. epidermidis biofilm 
samples using qPCR. This optimization included minimization of costs, and the maximization of 
reproducibility and sensitivity. To achieve that we assessed the three key steps of qPCR gene 
transcript analysis, namely RNA extraction, cDNA synthesis, and finally, the qPCR reaction. RNA 
extraction, as a first step, is often considered the most important step, since poor quality RNA will 
unquestionably influence the reliability and reproducibility of the downstream applications [7]. 
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Common indicators of RNA extraction success include the concentration, purity and integrity of RNA 
[20]. These indicators are influenced by both the sample’s nature and the principle of the RNA 
extraction kit used [21-23]. 
Complex samples, such as S. epidermidis biofilms, are notoriously difficult to disrupt and the high 
content of proteins and polysaccharides in the biofilm matrix can interfere with downstream 
analysis, as we have shown previously [9]. In that study, since FastRNA® Pro Blue was the only kit 
using mechanical lyses and had the highest performance, we tried to optimize the RNA extraction 
with the other kits tested (PureZOLTM from Bio-Rad and PureLinkTM from Invitrogen) by performing 
the mechanical lyses step of the FastRNA® Pro Blue kit, and using the lyses buffers included with the 
respective kits. However, this modification did not significantly increase the RNA yield [9], suggesting 
that the high efficiency of FastRNA® Pro Blue was not only due to the mechanical lyses, but also due 
to the chemical composition of the buffer. We have reported similar results for other bacterial 
species that form biofilms, such as Listeria monocytogenes [10].  
Analyzing FastRNA® Pro Blue buffer composition, we devised the custom procedure described here, 
wherein 90% phenol solution was added to the buffer of each silica-based membrane commercial 
kits in a proportion of 1:1. This approach significantly increased the RNA yield, with no detectable 
reduction of RNA purity and integrity. To see if other commercial silica-based column kits could also 
be used with this approach, three other kits were successfully tested. Of note, the FavorPrepTM kit 
was originally optimized to RNA extraction from human cells, but was easily adapted for bacterial 
cultures (Table 2.2). The custom protocols did not surpass the FastRNA® Pro Blue kit in terms of RNA 
quality or yield, however, we also evaluated the time necessary to perform the protocol and the cost 
associated with each one. In comparison with FastRNA® Pro Blue kit, we could achieve a 68% cost 
reduction, per reaction, when using our custom RNA protocol (Table 2.4 and Table 2.5). Furthermore, 
the overall experiment took us only 40 minutes to process 6 samples, versus nearly 4 hours with the 
FastRNA® Pro Blue.  
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Table 2.4. Analysis of the percentage of cost reduction when using the custom RNA extraction and qPCR 
instead of the commercially available kits. The price per reaction already includes all the extra-reagents 
needed. The values and comparison presented are relative to the price of largest kit available on the market. 
NA-not applicable. 
  Kit 
Price/ 
reaction (€) 
% of cost 
reduction 
RNA 
extraction 
Commercial FastRNA® Problue 7.15 NA 
Custom 
Based on PureLinkTM 5 30% 
Based on ISOLATE
TM
 4.2 41% 
Based on Direct-ZolTM 4 44% 
Based on FavorPrepTM 2.3 68% 
qPCR 
assay 
 
Commercial 
Maxima ® SYBR Green 
Master Mix 
0.48 NA 
Custom 
DyNAzyme
TM
 II PCR 
Master Mix+SYBR Green I 
0.13 73% 
 
Table 2.5. Kits and reagents used for the RNA extraction. All the prices listed were obtained by quote during 
January 2012. * ethanol is used on variable volume. An overestimated 1 mL volume was used for the purpose 
of price calculations. 
 
Kit (Manufacturer) 
Number extractions  
per kit 
Prices (€) per 
reaction 
FastRNA® Pro Blue (MPBiomedicals) 50 7.14 
PureLinkTM RNA Mini Kit (Invitrogen)  10-50 9.70-4.46 
ISOLATE RNA Mini Kit (Bioline) 10-250 5.30-3.68 
Direct-zolTM RNA MiniPrep (Zymo Research) 50-200 4.19-3.41 
FavorPrep Blood/Cultured Cell Total RNA (Favorgen) 50-300 2.50-1.80 
Ethanol 100% (Fisher)  2500* 0.006 
Chloroform (Fisher)  3333-8333 0.002-0.001 
Phenol (AppliChem) 277-1387 0.08-0.06 
Glass beads, acid-washed, 150-212 µm (Sigma) 25-1250  1.53-0.33 
RNAse & DNAse free tubes with screwcap 
(BioPlastics) 
500 0.12 
 
 
Without questioning the importance of RNA extraction step, a previous study regarding the 
optimization of cDNA synthesis using commercially available kits, revealed a high variability in the 
results obtained by some of the kits tested, indicating that the reverse transcriptase reaction is also 
crucial to obtain reliable measurement of mRNA transcripts [11]. Our results have also confirmed 
those observations [11], since a high variability was found in the quantification of cDNA obtained 
with different synthesis kits. Curiously, no significant variation was found in the reverse transcriptase 
kits when quantified by the iQTM SYBR® Green Supermix (p>0.05, ANOVA) (Figure 2.2). The presence 
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of PCR inhibitors in the cDNA was tested by serial dilution of the samples. Using the 2ΔCt method, a 
variation of the Livak method [24], if no PCR inhibitors are present in the cDNA, the relative fold 
increase of a specific gene should remain constant as cDNA is diluted (assuming a reasonable dilution 
range) [20]. While this was true for some cDNA synthesis kits, there were others that clearly 
contained PCR inhibitors. Using 100-fold cDNA dilution, we found that regardless the qPCR master 
mix used, no significant variation in gene expression quantification was detected, even when using 
different cDNA sources. 
In the Sieber et al. study, besides the reverse transcriptase variability, they also reported, although 
lower, some variability associated with the qPCR kit used [11]. Actually, the majority of the qPCR 
master mixes tested here, including the custom qPCR mix, presented similar efficiencies (85±6% 
average) with the exception of the PerfeCTa® SYBR Green SuperMix (78 ± 5%) (p<0.05, ANOVA). 
While many qPCR kits recommend the use of 50 µL reactions, we previously reduced the volume to 
25 µL and were able to properly detect gene expression both in E. coli [25] and S. aureus [26]. The 
reduction of reaction volume is appealing as it reduces the costs associated with an experiment. 
However, smaller volumes can introduce more pipetting errors and may reduce the limit of 
detection. To address this issue, reverse transcriptase and qPCR reactions were performed in either 
10 or 20 µL volumes.  
Interestingly, no significant differences were found between 10 or 20 µL qPCR reactions in any of the 
tested kits (Figure 2.4). On the other hand, with the cDNA synthesis kits tested, the variation was 
higher in 10 µL reverse transcriptase reactions, as noted by the higher standard deviation presented 
(Figure 2.5). The reduction of either cDNA or qPCR volume reaction from 20 to 10 µL, will 
unquestionably allow the reduction of some of the costs associated with gene expression analysis. 
Nevertheless, regarding the cDNA synthesis, we observed, in some particular cases, significant 
variability associated with reduced volume reactions. This higher variability would require an 
increase in the number of technical replicates in order to obtain reliable and meaningful results. 
Therefore, in our judgment, the reduction of the reverse transcriptase volume reactions might not be 
advantageous and ultimately, might not reduce overall costs (Table 2.6).  
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Table 2.6. cDNA synthesis kits used and price per reaction. All the prices listed were obtained by quote during 
January 2012. 
Kit (manufacturer) 
20 µL reactions 
per kit 
Prices (€) 
per reaction 
SuperScript® VILOTM synthesis (Invitrogen) 50-250 10.08-8.88 
RevertAid
TM
 First Strand cDNA synthesis (Fermentas) 20-100 4.25-2.80 
iScript
TM
 cDNA synthesis (Bio-Rad) 25-100 6.48-4.97 
qScriptTM cDNA synthesis (Quanta BioSciences) 25-500 4.52-3.04 
 
Contrary to the reverse transcriptase reaction, a reduction in the qPCR volume reaction was not 
associated with changes in the outcome of the experimental assay. Therefore, the use of 10 µL 
volume reaction instead of the 25 or 50 µL recommended by the manufacturer’s will allow to 
perform between 2.5 to 5 more reactions with the same cost (Table 2.7). A further approach to 
reduce experimental costs is to add SYBR Green I to a PCR mix, as such mixes are often considerably 
cheaper than qPCR mixes (Table 2.7).  
 
Table 2.7. qPCR kits and reagents used and prices per reaction. All the prices listed were obtained by quote 
during January 2012 * kit to which SYBR Green I was added.  
Kit (Manufacturer) 
20 μL reactions 
per kit 
Prices (€) 
per reaction 
mi-real-time EvaGreen® Master (Metabion) 250-1250 0.44-0.35 
Maxima ® SYBR Green Master Mix (Fermentas)  250-5000 0.81-0.48 
iQTM SYBR® Green Supermix (Bio-Rad) 250-5000 0.77-0.59 
PerfeCTa® SYBR® Green SuperMix (Quanta BioSciences) 250-5000 0.70-0.58 
DyNAzyme
TM
 II PCR Master Mix (Finnzymes)* 500-2500 0.12-0.11 
MyTaq
TM
 Mix (Bioline)* 500-2500 0.21-0.18 
EzWay Direct PCR Master Mix (Koma Biotech)*  100 1.40 
SYBR green I nucleic acid gel stain (Invitrogen) 12500-25000 0.03-0.02 
 
A fundamental step to be taken in consideration is an initial titration of the SYBR Green I, as a 
concentration can diminish the sensitivity and limit of detection and a higher concentration can 
inhibit the PCR reaction, as shown in our results. According to Figure 2.6, a titration of 0.5x SYBR 
Green I in DyNAzymeTM II PCR Master Mix, would be sufficient to detect the PCR products. However, 
as qPCR’s done using Maxima ® SYBR Green Master Mix would yield RFU levels of around 4000-5000, 
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we decided to use the 1× SYBR Green I concentration (since no PCR inhibition was detected) in order 
to obtain similar RFU levels.  
To validate our protocol, RNA from 4 different S. epidermidis strains grown in planktonic and biofilms 
from was extracted and analyzed as described. Several known genes involved in S. epidermidis 
biofilm formation, accumulation and modulation were selected as a control since their function and 
expression levels have been widely studied [27-33]. Both commercial and custom master mix 
detected the expected gene transcript levels in S. epidermidis biofilms when compared with 
planktonic cultures, validating our custom qPCR master mix (Table 2.3). Despite the statistically 
significant differences (p<0.05, paired-samples t-test) found between the commercial and the 
custom qPCR master mixes in the expression of S. epidermidis 9142 icaA, bhp and aap genes, or in S. 
epidermidis M129 and LE7 aap gene, these differences were small (below 1.8 fold), with no biological 
significance. Furthermore, both increases and decreases in transcript levels were detected in both 
experimental setups. Since the overall priming efficiency of the custom qPCR was similar to the 
commercial kits, we hypothesized that those small differences could be the result of variations in 
each SYBR Green I titration of the standard PCR mix, as we have detected some batch to batch 
variations in RFU and PCR efficiencies. As the initial cost of SYBR Green I is high, it can be used in 
other applications, such as agarose gel DNA/RNA staining. Once we thaw the aliquots, we kept them 
at 4oC, protected from light. We did not address the effect of storing SYBR Green I at 4oC, although 
the manufacturer indicates that short-term storage is possible. For future reference, smaller aliquots 
should be prepared, so that freshly thawed SYBR Green I could be used.  
The qPCR custom master mix developed in this study not only produced comparable results to those 
obtained using commercially available master mixes, it also, allowed considerable reduction in the 
cost associated with gene expression quantification, around 70% (Table 2.4). 
 
 
CONCLUSIONS  
Currently, qPCR is considered the gold standard technique to study transcript levels of a specific set 
of genes under specific treatment or stress conditions, and to validate the results obtained in 
genome-wide analysis such as DNA microarrays and RNA sequencing. Therefore, qPCR is a technique 
in high demand that has to assure high reliability, sensitivity and reproducibility. Herein, we describe 
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a custom procedure for RNA extraction and qPCR analysis that present the same high standards as 
the commercially available and reduces the high costs normally associated with gene expression 
quantification. 
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CHAPTER 3.  
 
S. epidermidis biofilm transcriptome alterations 
upon interaction with whole human blood  
 
 
 
ABSTRACT  
Pathogens that cause systemic infections typically present special features that 
help them to escape and colonize host’s organs. Obviously, the ability to 
withstand the high bactericidal activity of host’s blood is essential for biofilm 
maintenance, and thus essential for pathogenesis. Therefore, the mechanisms 
used by S. epidermidis biofilms to overcome and escape the high antimicrobial 
activity of human blood need to be identified and characterized. Hence, we 
aimed to elucidate S. epidermidis biofilms transcriptome dynamics when in 
contact with human blood. Gene ontology enrichment analysis showed that 
the up-regulated genes included those involved in biosynthesis and 
metabolism of amino acids, small molecules, carboxylic acid, ketones and 
glutamine. One of the striking changes observed was the increase in the 
expression of genes involved in iron recognition and uptake, suggesting that 
iron utilization may constitute one of the most important mechanisms used by 
S. epidermidis biofilms to survive in human blood.  
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BACKGROUND  
The most important virulence factor of S. epidermidis is its ability to tenaciously adhere to the surfaces of 
indwelling medical devices that penetrate the skin and form adhesive biofilms. Frequently, S. epidermidis 
develops biofilms on the surface of peripheral or central intravenous catheters, accounting, at least, for 
22% of the cases of bloodstream infections detected in patients in intensive care units in the USA [1]. 
Pathogens that cause systemic infections typically present special features that help them to escape and 
colonize host’s organs [2]. Obviously, the ability to withstand the high bactericidal activity of host’s blood 
is essential for biofilm maintenance, and thus indispensible in pathogenesis. Therefore, the mechanisms 
used by S. epidermidis to overcome and escape the high antimicrobial activity of human blood need to 
be identified and characterized. Due to the development of high-throughput nucleic acid identification 
and sequencing techniques, such as microarrays and RNA sequencing (RNA-seq), the analysis on how 
pathogenic microorganisms react during culture in human blood has been completed for important 
pathogens such as Candida albicans [2], Staphylococcus aureus [3], group A Streptococcus [4], 
Streptococcus agalactiae [5] and Enterococcus faecalis [6]. These data provided valuable information for 
understanding dissemination and virulence of these pathogens in the bloodstream. However, despite 
their importance in human health and disease, no such information has been reported regarding the 
transcriptome of biofilm cells for these pathogens or for S. epidermidis. The identification of S. 
epidermidis genes differentially expressed upon contact with human blood will be of crucial importance 
in understanding the strategies used by this bacterium to evade the host immune response and cause 
systemic infections. Since adaptive gene expression will determine whether bacteria successfully persist 
and disseminate in the host, in this chapter we describe the characterization of the transcriptome of S. 
epidermidis biofilms upon contact with human blood.  
 
 
MATERIALS AND METHODS 
Bacteria and growth conditions 
For this study, S. epidermidis RP62A was used. One single colony was inoculated into 2 mL of TSB and 
incubated overnight at 37oC and 700 rpm (VorTempTM 1550, Labnet International, USA). The overnight 
suspension was diluted 1:600 into fresh TSB supplemented with 1% glucose (v/v) (TSBG), distributed 
(1mL) into 24-well tissue culture plates (Costar®Corning) and incubated at 37oC, 100 rpm for 24 hours.  
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Blood collection and blood fractionation 
Peripheral blood was collected from healthy adult volunteers by venipuncture into BD Vacutainer® 
sodium heparin tubes (Becton Dickinson, NJ, USA). All donors gave written informed consent to have 
blood taken. Blood was collected under the 1999-P-001173/48 protocol approved by the Partner’s 
Health Care System Institutional Review Board (Boston, MA, USA).  
 
S. epidermidis biofilms co-incubation with whole human blood  
Twenty-four hour old S. epidermidis biofilms (grown as described above) were washed once with fresh 
TSB. Afterwards, 1 mL of whole blood or TSB was added to the wells containing the biofilms and allowed 
to incubate for 2 or 4 hours at 37oC in 5% CO2 with slight agitation. After the incubation period, blood 
and TSB were gently removed and the biofilms washed twice with phosphate buffered saline (PSB) with 
0.05% Tween20 (PBST) (Boston BioProducts, MA, USA), supplemented with a protease inhibitor cocktail 
tablet (Roche, Basel, Switzerland). The biofilms were immediately suspended in 1 mL of the RNA 
protectTM bacterial reagent (QIAGEN, Hilden, Germany) diluted 2:1 in PBS. Each condition was carried out 
in triplicate, and then the biofilms pooled together; 1.5 mL of this suspension was used for RNA 
extraction. This experiment was performed 6 independent times with different healthy blood donors. 
For cDNA library construction, 3 of the independent experiments were mixed together in order to 
decrease donor-dependent variation and 2 sets of independent samples were created.  
 
Total RNA Extraction 
RNA was extracted using RNeasy mini kit (QIAGEN) following the manufacturer’s instructions with some 
alterations (complete description in Chapter 2). RNA integrity was assessed using an Agilent 2100 
Bioanalyzer (Agilent Technologies, CA, USA). 
 
Removal of genomic DNA 
One cycle of TURBO DNA-free enzyme (Ambion, NY, USA) was performed following manufacturer’s 
recommendations. To improve genomic DNA removal and remove salts introduced by the DNase 
treatment, RNA was treated with a mixture of 1:5 Acid-phenol:chloroform (Ambion) (pH 4.5). Briefly, the 
RNA volume was adjust to 200 µL with nuclease-free water and transferred to phase lock heavy gel 
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tubes. Afterward, 200 µL of 1:5 Acid-phenol:chloroform was added, the tube inverted several times to 
mix, incubated for 3 minutes at room temperature (RT) and centrifuged for 2 minutes at 16000 g and 
4oC.The RNA fraction was then recovered by precipitation using 0.1 volume of 3 M sodium acetate 
(Ambion), 5 µg glycogen (Ambion) and ice-cold 100 % ethanol (Fisher Scientific) and incubated for 1 hour 
at 80oC. RNA was centrifuged at 16000 g for 30 minutes and 4oC, and washed twice with ice-cold 70 % 
ethanol (Fisher Scientific). The pellets were then centrifuged briefly and residual supernatant collected 
carefully. Finally RNA pellet was allowed to air-dry for 5 minutes at RT and dissolved in 30 µL of Tris-EDTA 
buffer (TE) (Ambion).  
 
Removal of eukaryotic RNA  
In order to remove any contaminating eukaryotic RNA derived from mammalian cells present in the 
blood, the samples were treated with MICROBEnrichTM kit (Ambion) following the manufacturer’s 
instructions. Briefly, 50 μg of RNA was prepared to hybridize with the magnetic beads to the 
polyadenylated 3’ ends of eukaryotic mRNA. The magnetic beads bound to the 18S and 28S rRNA and 
polyadenylated mRNA were pulled to the side of the tube with a magnet. The enriched bacterial RNA (in 
the supernatant) was transferred into a new tube and the RNA integrity assessed using a 2100 
Bioanalyzer (Agilent).  
 
 
 
Figure 3.1. RNA integrity profile of the samples used for the first (A) and second (B) RNA-seq runs. (1) RNA 
extracted from biofilms before the addition of blood, (2) 2 hours of incubation with TSB, (3) 2 hours of incubation 
with whole human blood, (4) 4 hours of incubation with TSB and (5) 4 hours of incubation with whole human 
blood. The RNA 6000 ladder was used and contains six RNA fragments ranging in size from 0.2 to 6 Kilobase. 
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Prokaryotic rRNA depletion 
Prokaryotic mRNA was enrich by depleting the ribosomal RNA using Ribo-ZeroTM rRNA removal kit for 
Gram-positive bacteria (Epicentre, WI, USA), following the manufacturer’s instructions. mRNA was 
recovered by precipitation as indicated by the manufacturer. The pellets were then dissolved in 18 μL of 
Elute, Prime and Fragment buffer (Illumina, San Diego, USA) a part of Illumina TruSeq verison 2 kit.  
 
Libraries preparation  
Library preparation for RNA-seq was performed using the Illumina TruSeqTM RNA kit, version 2 (Illumina) 
following the manufacturer’s instructions. Briefly, 400 ng of mRNA was chemically fragmented and 
immediately first and second strand complementary DNA (cDNA) prepared. Later, the overhangs were 
converted into blunt ends and a single A-nucleotide was added to the 3’ends allowing the ligation of 
different bar codes. At the end, a selective enrichment of the double stranded-cDNA fragments that had 
adapter molecules on both ends was performed by PCR. Library construction was validated through a 
high quality control: 1) Agilent 2200 TapStation System (High Sensitivity D1K Screen Tape) to determine 
the size of the products, which should be around 260-300 base pairs, and 2) quantitative PCR to 
determine functionality (hybridization to flow cell) and the exact concentration of the libraries to create 
optimum cluster densities across every lane to obtain the highest quality data on Illumina sequencing 
platforms.  
 
Figure 3.2. Sizes of the libraries created for RNA-seq run 1 (A) and 2 (B). Libraries prepared with RNA extracted 
from biofilms at time 0 (1), 2 hours post incubation with TSB (2) or whole human blood (3) and, 4 hours post 
incubation with TSB (4) or whole human blood (5). The DNA ladder contains five DNA fragments ranging in size 
from 0.2 to 1 kilobase pairs.  
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RNA-seq data analysis 
The reads obtained were aligned to the genome of S. epidermidis RP62A (RefSeq accession number 
NC_002976.3), and the total reads/gene were normalized using reads per kilobase per million (RPKM), 
that account for both library size and gene length effects within-sample comparisons, as described by 
Mortazavi and his collaborators [7]. Differential gene expression between biofilms incubated with TSB or 
human blood, and biofilms at the start of the culture was then calculated. In order to determine 
statistically significant differences in gene expression between the tested conditions, Baggerly’s 
statistical [8] test with false discovery rate (FDR) and p values correction was applied [9]. All these steps 
were performed using CLC Genomics Workbench version 5.1 (MA, USA).  
Genes that were not detected (RPKM=0) and with fold changes with p values greater than 0.05 were 
discarded. Using Venn diagrams [10] the genes that were expressed in both biological replicates were 
identified. A list of the fold change values obtained in each run, for each gene, was created and the 
values were averaged. Pearson correlation was performed in order to assess the agreement between 
biological replicates. For further analyses, only genes with fold changes above two were selected for 
inclusion.  
Finally, in order to simplify the global analyses and to identify the principal biological processes 
enhanced upon contact with human blood, gene ontology (GO) enrichment of the up- and down-
regulated genes was accomplished using the Search Tool for the Retrieval of Interacting Genes/Proteins 
(STRING) version 9.05 [11]. Only gene-sets passing significance thresholds (FDR, p value<0.05) were 
selected for display. The visualization of the interactions between genes was performed using Cytoscape 
version 2.8.3 [12]. Protein localization within the bacterial cell was predicted using PSORTb version 3.0.2 
[13]. 
In order to confirm the data obtained by RNA-seq, a few genes of interest were selected (Table 3.1) and 
qPCR performed as described in Chapter 2. 
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Table 3.1. Oligonucleotide primer sequences used for RNA-seq confirmation by qPCR. 
 
 
 
 
 
 
 
 
Assessment of biofilms viability upon exposure to human blood by flow cytometry  
Biofilm viability was determined by flow cytometry as described elsewhere [11,12], with minor 
alterations. In brief, biofilms were washed twice, suspended in 1 mL of PBS, sonicated for 10 seconds at 
18 Watt (Branson model W 185 D ultrasonic cell disrupter; Heat Systems-Ultrasonics, Plainview, New 
York, USA), and vortexed at maximum speed. Finally, 180 µL of a solution with SYBR green I (1:5000 
dilution, Invitrogen, California, USA), 1 µg/mL of propidium iodide (PI) (Sigma, MO, USA), 10 µL of 
quantification beads, and 10 µL of 1:100 diluted bacteria were mixed together by vortexing and the cells 
counted in a Coulter EPICS XL flow cytometer (Beckman Coulter, Inc., CA, USA). SYBR green I 
fluorescence was detected on the FL1 channel while PI fluorescence was detected on the FL3 channel. 
For all detected parameters, amplification was carried out using logarithmic scales. The concentration of 
bacteria was determined by acquiring the counts for a specific number of microspheres. Statistical 
differences between groups were determined using unpaired t-test and p values less than 0.05 were 
considered significant. 
 
 
RESULTS AND DISCUSSION 
Confirmation of RNA-seq results  
In order to confirm the results obtained with RNA-seq analysis, 4 genes of interest were selected and 
their expression determined by qPCR using the same biological model. As can be seen in Table 3.2, 
Target gene  primers sequence (5’ to 3’) TM (
oC) Amplicon size (bp) 
16S 
FW GGGCTACACACGTGCTACAA 59.79 
176 
RV GTACAAGACCCGGGAACGTA 59.85 
aap 
FW GCACCAGCTGTTGTTGTACC 59.22 
190 
RV GCATGCCTGCTGATAGTTCA 59.98 
bhp 
FW TGGACTCGTAGCTTCGTCCT 60.01 
213 
RV TCTGCAGATACCCAGACAACC 60.13 
icaA 
FW TGCACTCAATGAGGGAATCA 60.20 
134 
RV TAACTGCGCCTAATTTTGGATT 59.99 
lrgB 
FW ATATCGCAAGCGCGAAGTAT 59.87 
165 RV ATTGCTGTCGTTGCAGCTT 59.61 
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although qPCR was able to detect higher amount of mRNA transcripts [3,4,6], the trend observed was 
the same as in RNA-seq. Thus, these results validated and confirmed the results obtained using RNA-seq 
analysis.  
 
Table 3.2. Verification of the RNA-seq data by qPCR. Results are expressed as the mean of relative fold expression 
obtained in 3 independent experiments plus or minus standard error of the mean from bacteria cultured in blood 
for 2 or 4 hours comparatively to the time zero. ND-not detected; NA-not applicable.  
 
 T2h blood T4h blood 
Gene RNA-seq qPCR RNA-seq qPCR 
aap 2.76 ± 1.95 8.97 ± 3.65 1.77 ± 0.459 11.64 ± 1.99 
bhp 2.36 ± 1.67 8.49 ± 3.92 ND NA 
icaA 31.16 ± 22.03 89.64 ± 73,93 21 ±2.73 223.98 ± 44.88 
lrgB 113.08 ± 79.96 10.25 ± 4.67 78.7 ± 65.6 25.86 ± 7.68 
 
 
S. epidermidis biofilms survival in human blood 
Human blood is a complex mixture of immune circulating cells and soluble factors that are very active 
against invading pathogens. However, pathogens that promote systemic infections have developed 
mechanisms that enable them to circumvent the high microbicidal properties of the host’s blood [14]. In 
order to evaluate the stress induced by human blood on the ability of cells within S. epidermidis biofilms 
to survive, biofilm viability was evaluated by flow cytometry. Despite some lost of viability, we have 
determined a survival percentage of 59% ± 11.4% and 54% ± 5.6%, respectively, upon 2 and 4 hours 
incubation with whole human blood (Figure 3.3). These results clearly show the ability of S. epidermidis 
biofilms to survive in such harsh environment, and the importance of studying the mechanisms 
employed by the bacterium to survive, which ultimately will allow dissemination into host’s organs and 
cause infection. 
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Figure 3.3. Total number of viable cells per biofilm upon incubation with human blood for 2 (A) and 4 (B) hours. 
The total number of viable cells was assessed by flow cytometry using SYBR green I/ PI staining. The bars represent 
the average plus or minus the standard error of the mean of 4 to 6 independent experiments. Statistical difference 
between groups was determined using unpaired t-test.  
 
The ex vivo model and global transcriptomics analysis 
To gain enhanced understanding of the mechanisms used by S. epidermidis to survive and evade the 
anti-bacterial activities of human blood, global changes in its transcriptome upon contact with blood 
were assessed. Obviously, the most relevant data would be provided by analyzing bacterial gene 
expression during the progress of biofilm-related infections in patients. However, this kind of study is 
extremely difficult, if not impossible, to conduct. A model that completely mimics the in vivo 
environment with the inclusion of all the variables which are likely to influence bacterial responses and 
the course of infection is inaccessible [4]. Nevertheless, the incubation of microorganisms with human 
blood samples seemed to be an attractive model for mimicking in vivo environment, and has been 
increasingly used in the last years [2-6,14-16]. Thus, S. epidermidis biofilms were incubated with 
heparinized human blood for 2 or 4 hours. Sodium heparin was chosen as anticoagulant over EDTA or 
sodium citrate due to its action on anti-thrombin III rather than ions that may be essential for bacterial 
growth [17]. Furthermore it was shown that group B meningococci incubated with blood samples 
collected with sodium citrate were killed faster than in heparinized blood. On the other hand, another 
study has reported that Candida albicans gene expression is influenced by the presence of heparin in 
blood samples. Nevertheless, only a very small group of genes (10 out of 2002) was affected [14]. 
Importantly, when working with human samples, there is a significant source of variability that is due to 
differences among individual. It is known that factors such as age [18], gender [19], exposure factors 
such as smoking, diet and medication [20], the proportion of the different cell populations comprising 
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the blood [21], and even the time of day at which the sample was taken are responsible for inter-
individual sample variation [22]. In order to reduce possible donor-associated gene expression variability, 
blood from 6 different donors was used for this experiment. At the end, total RNA resultant from 3 of 
these 6 experiments were pooled together creating two set of samples that were processed 
independently. Nevertheless, besides the attempt to decrease donor-dependent variability, differences 
between biological duplicates were observed (Figure 3.4), resulting in Pearson correlation coefficients of 
0.7 and 0.8, respectively, 2 and 4 hours after incubation with human blood. 
 
 
 
Figure 3.4. Venn diagrams showing the number of common transcripts (overlapping circles) and unique 
transcripts (non-overlapping circles) between the 2 biological replicates upon 2 (A) or 4 (B) hours of incubation 
with whole human blood. All further analysis was performed using the 680 and 1195 genes that are common to 
both independent experiments in order to study phenomena that are present in all donors.  
 
In order to study S. epidermidis transcriptome changes independent of donor variability, only genes that 
were differentially transcribed in both samples (Figure 3.5) were considered for further analysis. 
Additionally, in order to distinguish between alterations caused by the unique environment of human 
blood and non-specific alterations required for growth in fresh medium, biofilms were also incubated 
with TSB, a medium regularly used in laboratory studies for staphylococcus growth. The identification of 
the genes uniquely expressed in blood will be important both for understanding the infection process 
and also to uncover the specific mechanisms employed by the bacterium for immune evasion. As can be 
seen in the Figure 3.5, within 680 genes only 139 genes were uniquely expressed in biofilms after 2 hours 
of exposure to whole human blood. Within these 139 genes, 41 (29.49%) were up-regulated and 34 
(24.46%) down-regulated, while 63 genes (45.3%) presented very small changes in their transcription 
(around 2-fold change). Four hours after exposure, among the 1195 genes differentially expressed, only 
445 genes were uniquely expressed in the presence of human blood, whereas 94 (21.12%) were up-
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regulated and 97 (21.79%) down-regulated, while 254 (57.08%) presented very small changes in their 
expression profile (around 2-fold change). Hence, for further analysis only the genes that were uniquely 
expressed in the presence of human blood were considered for inclusion. 
 
 
 
Figure 3.5. (A) Venn diagram showing the number of common transcripts (overlapping circles) and unique 
transcripts (non-overlapping circles) in all the conditions tested; (B) Network of the interactions of all the genes 
uniquely expressed within biofilms exposed for 2 (B1) or 4 hours (B2) to human blood. Nodes represent genes 
that are connected with edges representing pair-wise interactions. Colors indicate up-regulated genes (dark green), 
down-regulated genes (red) and genes that presented with small variations in their expression (around 2-fold 
change) (light green).  
 
S. epidermidis biofilms major transcriptomic changes upon contact with human blood 
Upon contact with human blood, S. epidermidis biofilm transcriptomes undergo dramatic changes in 
response to the stress created by the presence of human blood components. To better understand the 
significance of the changes it is essential to narrow down the analysis of such complex data and to 
highlight the most important biological processes occurring. Hence GO enrichment analysis was 
performed using STRING. As can be seen in the Figure 3.6, the biological processes that were found 
enhanced within the up-regulated genes 2 hours after incubation with human blood are linked to amino 
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acid, small molecules and carboxylic acid biosynthesis. After 4 hours of exposure, it was also found that 
genes involved in the biosynthesis of organic acids, cellular ketone and glutamine, as well as oxoacid and 
carboxylic acid metabolism were also enhanced. No enhancement in biological processes within down-
regulated genes 2 or 4 hours after incubation with human blood was found. Interestingly, the up-
regulation of amino acid biosynthesis and metabolism was also observed in S. aureus both during blood 
[3] and lung infection [23], as well as in other microorganisms such as group A Streptococcus [4] and 
Candida albicans [14] when incubated with human blood.  
 
 
 
Figure 3.6. Percentage of up-regulated genes within the different biological functional classes upon 2 or 4 hours 
of exposure to human blood. GO enrichment was performed using STRING. Only set-genes with p values less than 
0.05 (with FDR) were selected for display.  
 
Biofilm formation and virulence determinants  
One of our primary interests was to assess the changes that occurred in the expression of genes involved 
in the biofilm lifecycle and immune evasion. A closer look into several of those genes (Table 3.2) revealed 
that those involved in the biofilm lifecycle as well as in immune evasion were up-regulated in both blood 
and TSB cultures. However, in the first 2 hours after exposure to human blood, genes that promote 
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biofilm formation genes such as aap, bhp, icaA were expressed at lower levels while the negative 
regulator saeR was found expressed at higher levels in cells within biofilms under humans blood stress. 
This decrease in biofilm formation is probably related to an efficient energetic strategy, whereby the 
energy applied for other functions not related to bacterial survival in human blood is redirected.  
 
Table 3.3. Expression of genes involved in biofilm formation and immune evasion during exposure to human 
blood for 2 and 4 hours. ND-not-detected; IgG-immunoglobulin G; CP-complement proteins. 
 
As we observed previously by GO enhancement, biological processes such as amino and carboxylic acid 
biosynthesis and metabolism were enhanced rather than genes involved in virulence or biofilm 
formation. Nevertheless, 4 hours after exposure to human blood, a slight increase in the expression of 
several of these genes seemed to indicate that bacteria started adapting to the environment created by 
the human blood components. Thus, the expression of genes involved in biofilm maintenance and 
virulence started to increase, reaching or even surpassing the expression observed within biofilms 
incubated with TSB. Interestingly, in the case of the response regulator saeR this was not observed. 
Despite the involvement of saeR in biofilm formation through the repression of proteases and nucleases 
that are involved in biofilm dispersion [24], it was also shown that saeR is responsive to several 
phagocytosis-related stimuli including pH, oxidative stress and the presence of defensins, factors 
essential for immune evasion [25-27]. Furthermore, in agreement with our findings, it was found that 
saeR is also up-regulated in S. aureus upon incubation with human blood [3]. Additionally, it was found  
that saeR expression increases  in the presence of hemoglobin [28].  
Gene 
Fold change (2h) Fold change (4h) 
Function 
TSB Blood TSB Blood 
aap 3.4 2.7 ND 1.7 Bacterial aggregation after proteolysis 
atlE 6 3.6 1.6 2.4 Binding to polystyrene and vitronectin 
bhp 5.5 2.3 1.7 ND Bacterial cell-cell interaction 
capB 6.7 ND 2.8 2.4 Protects from AMPs and phagocytes 
gehD 7 3.1 2.3 5.4 Binding to collagen; Persistence on skin 
gehC ND 3.1 3.6 7.8 Persistence on skin 
icaA 67 31 15.07 21.0 
Protects from AMPs, phagocytes, IgG and CP; 
Bacterial cell-cell interaction 
saeR 16 101 10.6 105 Two component signaling system 
sepA 3.05 ND ND ND Involved in AMPs degradation 
sdrG 6.7 11 2.08 4.3 Binding to fibrinogen 
sdrF 1.8 ND ND ND Binding to collagen 
sspA 1.07 1.7 ND 1.4 Serine protease 
sspB ND ND ND ND Tissue damage 
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Iron uptake and sequestration  
Genes associated with iron uptake, recognition and sequestration were found up-regulated 4 hours after 
incubation with human blood (Table 3.4). Interestingly, some genes were also shown to be up-regulated 
in TSB, but only in the first 2 hours of incubation. Iron is an essential cofactor in basic metabolic 
pathways to both pathogenic microorganisms and their hosts. During the years of co-evolution, the 
shared requirement for both the pathogen and the host to acquire and use iron has shaped the 
pathogen–host relationship [29,30]. For bacteria, iron is essential in many biological processes such as 
nucleotide biosynthesis, aerobic respiration, tricarboxylic acid cycle and oxidative defense systems that 
protect bacteria from the reactive oxygen species produced by the host [30,31]. Thus, not surprisingly, 
almost all bacteria require iron to grow and establish infection in their hosts [29]. Hence, one of the first 
lines of defense against bacterial infection is sequestering iron to prevent bacterial outgrowth in a 
process termed nutritional immunity [32].  
 
Table 3.4. Genes involved in iron uptake and metabolism that were found differentially expressed 2 and 4 hours 
after incubation with human blood. The localization each of the protein was determined using PSORTb version 
3.0.2. ND-not-detected; a-this receptor may be located on the cell wall, extracellular or in the cytoplasmic 
membrane. 
 
Gene 
Fold change 
(2h) 
Fold change 
(4h) 
Function Localization 
SERP0400 16.6 19.4 
Iron compound ABC transporter, permease 
protein 
Cytoplasmic 
membrane 
SERP0401 15.7 18.0 
Iron compound ABC transporter, permease 
protein 
Cytoplasmic 
membrane 
SERP0402 11.8 10.0 
Iron compound ABC transporter, ATP-
binding protein 
Cytoplasmic 
membrane 
SERP0949 8.0 8.0 Transferrin receptor Unkown
a
 
SERP0403 30.9 7.3 Transferrin receptor 
Cytoplasmic 
membrane  
SERP1953 ND 4.16 
HssR, two-component regulatory system 
HssRS  
Cytosplasmic 
SERP1775 5.5 3.81 
Iron compound ABC transporter, permease 
protein 
Cytoplasmic 
membrane 
SERP1776 4.5 3.05 
Iron compound ABC transporter, permease 
protein 
Cytoplasmic 
membrane 
SERP0306 ND 2.75 
Iron compound ABC transporter, ATP-
binding protein 
Cytoplasmic 
membrane 
SERP1951 ND -2.70 
HrtA, ABC transporter complex HrtAB 
involved in hemin import 
Cytoplasmic 
membrane 
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In humans, iron is primarily found sequestered within ferritin (iron storage protein) or transferrin (iron 
transporter), or complexed within the porphyrin ring of the heme cofactor of hemoglobin and myoglobin 
(oxygen carrying and storage proteins) being, thus, inaccessible to bacteria [33]. This way, the host 
environment contains very low levels of free iron (10-18M) [23,32,34]. Nonetheless, pathogenic bacteria 
have evolved several mechanisms that are able to sequester iron present in the host [34]. One of the 
mechanisms described for S. aureus is the use of the two component Heme-Sensor System (HssRS). This 
system responds to heme, hemin, hemoglobin or blood and activates the expression of the heme-
regulated transporter (HrtAB) efflux pump, an ABC-type transporter involved in the alleviation of hemin 
toxicity and thus, playing a pivotal role in the intracellular heme homestasis [35,36]. Orthologs of hssRS 
and hrtAB are also found in S. epidermidis as well as other Gram-positive bacteria, suggesting a 
conserved mechanism by which these pathogens can acquire iron and modulate virulence [35,37,38]. 
Although 2 hours after incubation with blood both hssRS and hrtAB were not expressed, after 4 hours, as 
can be observed in the Table 3.4, the expression of the DNA-binding response regulator hssR is increased 
indicating that hssS was activated and therefore the bacterial cells are sensing the presence of heme in 
the cytoplasm. However, hrtA was found down-regulated. Not being mobilized, heme is excreted via 
HrtAB complex to avoid heme-related toxicity the down-regulation of hrtA suggests that all the heme in 
the cytoplasm was used for other cellular functions [35]. 
Besides this two component sensing system there are also important transferrin receptors that recognize 
specifically transferrin from the human blood and use the iron that is bound for cellular functions 
[39,40]. These results clearly indicate that iron uptake may constitute an important mechanism of 
survival in human blood. The requirement for iron ensures that the systems involved in iron uptake are 
located at the surface during infection. Thus, the inactivation of these receptors and systems have been 
proposed as interesting candidate vaccines for several pathogens including Neisseria meningitides [41], 
the Hemophilus ducreyi [42], S. aureus [43], and E. coli [44].  
 
 
CONCLUSIONS  
Characterization of the bacterial transcriptome during host-pathogen interactions is a fundamental step 
to understand the infectious processes caused by human pathogens. In this chapter, we have described, 
for the first time, S. epidermidis biofilms transcriptome upon exposure to human blood using an ex vivo 
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model of infection. A careful analysis revealed that S. epidermidis biofilms undergo a rapid adaptive 
response that enable it to survive and persist in host’s blood over the time course of the infection. 
Moreover, these results indicate that S. epidermidis survival in human blood is primarily related to the 
ability to synthesize several essential molecules that are not available in this setting, rather than the 
expression of classic virulence factors, implying a protective rather than an aggressive strategy of 
survival. In addition, iron recognition and uptake seems to be the one of the most important 
mechanisms that S. epidermidis biofilms use to respond to the presence of human blood. This issue 
needs to be further investigated in order to determine if this mechanism may be used to identify 
potential vaccine candidates based on their in vivo expression as has already been proposed for other 
pathogenic bacteria.  
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Table S 3.1. List of top 10 up- and down-regulated genes uniquely expressed in biofilms upon 2 hours of 
contact with whole human blood. The localization each of the protein was determined using PSORTb. a-this 
protein may be located on cytoplasm or cytoplasmic membrane.  
 
Gene Fold change                                   Product Localization 
Up-regulated  
SERP2326 228.7 acetoin dehydrogenase, E1 component, alpha subunit Cytoplasmic 
ppdk 30.4 pyruvate phosphate dikinase Cytoplasmic 
leuA 19.3 2-isopropylmalate synthase Cytoplasmic 
ilvC 16.7 ketol-acid reductoisomerase Cytoplasmic 
SERP0479 14.6 truncated IS1272 transposase Unknown 
hisD 13.4 histidinol dehydrogenase Cytoplasmic 
hom 11.8 homoserine dehydrogenase Unknown 
SERP1780 11.0 transporter, putative 
Cytoplasmic 
membrane 
SERP2260 11.0 PTS system, fructose-specific IIABC components 
Cytoplasmic 
membrane 
Down-regulated 
SERP0079 -6 hypothetical protein Cytoplasmic 
SERP0244 -5.6 oxidoreducatese, Aldo/Keto reductase family Cytoplasmic 
mqo-3 -5.5 malate:quinone oxidoreductase Cell wall a 
SERP1868 -5.3 Transporter, putative 
Cytoplasmic 
membrane 
SERP0080 -4 cobalamin synthesis protein Cytoplasmic 
moaB -3.4 molybdenum cofactor biosynthesis protein B Cytoplasmic 
SERP0294 -2.9 hypothetical protein 
Cytoplasmic 
membrane 
scdA -2.9 cell wall biosynthesis  Cytoplasmic 
SERP1664 -2.8 hypothetical protein Cytoplasmic 
SERP2173 -2.7 hypothetical protein cytoplasmic 
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Table S 3.2. List of top 10 up- and down-regulated genes uniquely expressed in biofilms upon 4 hours in 
contact with whole human blood. The localization each of the protein represented was determined using 
PSORTb.  
 
 
 
 
Gene Fold change                                   Product Localization 
Up-regulated 
leuD 31.9 isopropylmalate isomerase small subunit Unknown  
SERP1395 27.7 amino acid ABC transporter substrate-binding protein  
Cytoplasmic 
membrane 
SERP1864 26.3 bioY family protein 
Cytoplasmic 
membrane 
SERP0400 19.4 iron compound ABC transporter, permease protein 
Cytoplasmic 
membrane 
SERP0401 18.0 iron compound ABC transporter, permease protein 
Cytoplasmic 
membrane 
SERP1703 18.0 single-stranded DNA-binding protein family Cytoplasmic 
ilvA 17.7 threonine dehydratase Cytoplasmic 
SERP2141 17.3 regulatory protein, putative 
Cytoplasmic 
membrane 
argC 11.1 N-acetyl-gamma-glutamyl-phosphate reductase Unknown 
SERP0402 10.0 iron compound ABC transporter, ATP-binding protein 
Cytoplasmic 
membrane 
Down-regulated 
arcB-1 -120.0 ornithine carbamoyltransferase Cytoplasmic 
arcA -75 arginine deiminase Cytoplasmic 
arcD -60.4 arginine/ornithine antiporter 
Cytoplasmic 
membrane 
SERP0958 -16.8 phosphate ABC transporter, permease protein 
Cytoplasmic 
membrane 
cysS -12.4 cysteinyl-tRNA synthetase Cytoplasmic 
SERP0171 -10.7 hypothetical protein Cytoplasmic 
SERP2005 -10.6 amino acid ABC transporter, amino acid-binding protein Unknown 
SERP2425 -8.7 hypothetical protein 
Cytoplasmic 
membrane 
SERP1655 -7.9 hypothetical protein 
Cytoplasmic 
membrane 
SERP0094 -7.9 
cysteine synthase/cystathionine beta-synthase family 
protein 
Unknown 
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CHAPTER 4. 
 
S. epidermidis biofilm-released cells: phenotype 
characterization and a first look into its interaction 
with the host immune system 
 
 
 
ABSTRACT 
S. epidermidis biofilm disassembly has been associated with the development 
of serious biofilm-associated infections. However, little is known about the 
phenotype and the interaction of biofilm-released cells with the host immune 
system. In this chapter we describe the characterization of biofilm-released 
cells in several important parameters such as antibiotic susceptibility, total 
protein and gene expression profiles, the ability to adhere to abiotic surfaces 
and their susceptibility to human immune effectors using in vitro and in vivo 
models. The results showed that biofilm-released cells present a particular 
phenotype. These cells display, simultaneously, features of planktonic cells, 
such as expression of psmβ and icaA, or the ability to colonize host organs in 
the first hours of infection, as well as biofilm features, such as high antibiotic 
tolerance, and lower ability to stimulate the production of IL-6. Moreover, S. 
epidermidis biofilms produced a unique protein that is not detected in the 
other phenotypes. Hence, this study shows, for the first time, that S. 
epidermidis biofilm-released cells present an intermediary phenotype, that 
should be take into consideration in the pathogenesis of biofilm-related 
infections.  
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BACKGROUND  
Biofilm disassembly, the release of bacterial cells within the biofilm into the involving environment, has 
been associated with the development of severe infections such as bacteremia [1], embolic events of 
endocarditis [2] and pneumonia [3]. However, despite its clear importance in the clinical setting, little is 
known about the particular features of the biofilm-released cells and their interaction with the host 
immune system. Similarly to the other phases of the biofilm lifecycle, biofilm disassembly is believed to 
be a combination of complex, multi-factorial, and highly regulated processes that can be triggered by 
several external and/ or by bacterial-derived signals [4-6]. In the beginning of the biofilm formation, 
planktonic attached bacteria undergo several physiological and genetic expression modifications that will 
lead to the biofilm phenotype [7]. Reasonably, it was initially hypothesized that after disassembly, 
biofilm-released cells would revert to the initial planktonic phenotype [8]. However, it has been recently 
shown that cells released from Pseudomonas aeruginosa [9] and Streptococcus mutans [10] biofilms 
present particular and distinctive features from the ones presented by their planktonic and biofilm 
counterparts. An in-depth understanding of the particular properties of biofilm-released cells and its 
interaction with the host immune system is needed to help to prevent the pathologic events associated 
with biofilm cells dissemination to more distant sites. Therefore, in this chapter, we describe S. 
epidermidis biofilm-released cells ability to adhere to abiotic surfaces, tolerance to antibiotics, total 
protein profile, expression of genes with particular interest in biofilm formation, maturation, and 
disassembly, and tolerance to opsonophagocytic killing. In addition, the ability of these cells to colonize 
systemic organs and persist within the host was also evaluated. 
 
 
MATERIALS AND METHODS  
Bacteria and growth conditions 
For this study, the biofilm forming strain S. epidermidis 9142 was used [11]. One single colony grown in 
Tryptic Soy Agar plates (TSA, Liofilchem, Roseto degli Abruzzi, Italy) was inoculated into 2 mL of Tryptic 
Soy Broth (TSB, Liofilchem) and incubated overnight at 37oC and 120 rpm. The overnight-grown cells 
were diluted in TSB in order to obtain a suspension with an optical density (OD) at 640 nm of 0.250 (±0.5) 
which correspond, approximately, to 1.5 × 108 Colony Forming Units (CFU)/mL. Biofilms were formed by 
inoculating 15 µL of this suspension into 1 mL of TSB supplemented with 0.4% (v/v) glucose (TSBG), and 
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incubated in a 24-well plate (Orange Scientific, Braine-l'Alleud, Belgium) at 37oC and 120 rpm. Twenty-
four hours later, spent medium was removed and the biofilms were washed twice with phosphate 
buffered saline (PBS, Boston Bioproducts, MA, USA). One mL of fresh TSBG was then carefully added to 
allow additional 24 hours growth in the same conditions. Planktonic cultures were prepared by adding 
150 µL of a bacterial suspension with OD640nm of 0.250 (±0.5) into 10 mL TSBG, and incubated for 24 
hours at 37oC and 120 rpm.  
 
 
Figure 4.1. Schematic fed batch model used to collect S. epidermidis biofilm-released cells. 
 
Prior to any of the analysis described below, biofilm-released cells were collected by careful aspiration of 
the biofilm culture supernatants; biofilms were washed twice with PBS, and then suspended in 1 mL of 
TSB (for antibiotic assays) or PBS (for the other studies) by scraping the cells from the plastic surface. 
Afterwards, planktonic, biofilm and biofilm-released cells were sonicated for 15 seconds at 7 Watt 
(VC600, Sonics, CT, USA) in order to dissociate cell clusters and create a homogenous suspension. The 
viability of the suspended cells was not reduced by this methodology, as determined before [12].  
 
Total proteins extraction 
Total proteins extraction of the different S. epidermidis cell preparations was performed by using 
lysostaphin digestion as described elsewhere [13], with some modifications. In brief, each population 
was grown and processed as described above. Afterwards, the OD640nm of each population was adjusted 
to 1, which corresponds to approximately 1 × 109 CFU/mL, and 2 mL of each suspension harvested by 
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centrifugation for 10 minutes at 16000 g and 4oC. Pellets were washed twice with PBS, and finally 
suspended in 200 μL of PBS supplemented with 300 μg/mL of lysostaphin (Ambicin® L, AMBI, Inc., NY, 
USA) and a tablet of protease inhibitor cocktail (Roche, IN, USA). This suspension was incubated for 90 
minutes at 37oC with rocking. After the lysostaphin digestion, the suspensions were centrifuged for 15 
minutes at 8000 g and 4oC to remove protoplasts. The supernatants were then transferred into a new 
tube and treated with TurboTM DNase (Ambion, CA, USA) for 30 minutes at 37oC. Finally, proteins were 
recovered with acetone precipitation, adding 4 volumes of ice-cold acetone to the suspension, and 
followed by an overnight incubation at -20oC. Proteins were recovered by 30 minutes centrifugation at 
16000 g and suspended in 100 μL of PBS. Total proteins were quantified using NanodropTM1000 (Thermo 
Scientific, MA, USA) and the concentration between samples normalized to 30 μg, in NuPAGE® LDS 
(Novex®, CA, USA) sample buffer and NuPAGE® Sample Reducing Agent (Novex®). The samples were 
boiled for 5 minutes and then loaded into NuPAGE® Novex 4-12% Bis-Tris Gel (Novex®) that was 
immersed in MEPs buffer (Novex®). Electrophoresis was carried out at 120 Volts for 60 minutes. The gel 
was stained with Bio-Rad silver stain (Bio-Rad, CA, USA) following the manufacturers’ instructions.  
 
RNA extraction  
Total RNA extraction was performed by using FastRNA® Pro Blue (MP Biomedicals, CA, USA) kit with 
small modifications, as described before [14]. In brief, the different S. epidermidis populations were 
harvested by centrifugation for 10 minutes at 16000 g and 4oC. Bacterial pellets were then suspended in 
850 µL of RNApro™ Solution and transferred into lysing matrix B tubes (supplied by the kit). The lyses 
was then carried out using the Fast PrepTM cell disruptor FP120 (Thermo Scientific) at 6.5 meter/second 
for 35 seconds. This cycle was repeated 3× with intervals of 5 minutes on ice. The tubes were then 
centrifuged, supernatants transferred into a new tube, mixed with 300 µL of chloroform (Sigma, MO, 
USA), incubated at room temperature (RT) for 5 minute and finally, centrifuged for 5 minutes at 4oC and 
16000 g. This step was repeated twice in order to obtain higher purity. The aqueous phase was then 
carefully transferred into a new tube, mixed with cold 100% ethanol and incubated at -20oC for at least 
30 minutes. RNA was recovered by 30 minutes centrifugation at 16000 g and 4oC. RNA pellets were 
washed twice with 75% ethanol and suspended in 50 µL of DEPC-treated water. In order to remove any 
co-purified genomic DNA, one step of DNase treatment (Fermentas, Ontario, Canada) was performed 
following the manufacturer’s instructions. RNA quantity (ng/µL) and purity (A260/A280 and A260/A230) were 
assessed using NanodropTM 1000 (Thermo Scientific) spectrophotometer. RNA integrity was determined 
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by electrophoresis loading 1-2 µg of RNA sample into a 1.5% agarose gel and run at 80 Volts for 60 
minutes in 1 × Tris Acetate-EDTA buffer. The bands were reveled with ethidium bromide (Fisher 
Scientific, PA, USA) and images were taken using the Gel Doc 2000 (Bio-Rad).  
 
Confocal laser scanning microscopy  
Confocal laser scanning microscopy (CLSM) was used to evaluate the presence of PNAG on the surface of 
the three S. epidermidis populations, as elsewhere described [15,16]. Briefly, cells were washed twice 
with PBS and a 10 µL aliquot of each cell suspension was air-dried onto a glass slide. Bacteria were fixed 
to the slide with methanol for 1 min at RT. At this point S. epidermidis cells were incubated for 2 hours at 
RT with antibodies anti-PNAG, human monoclonal antibody F598 conjugated to Alexa Fluor 488 at 5.2 
µg/mL, in PBS with 0.5% bovine serum albumin (BSA) and 10% NRS. As controls we included S. 
epidermidis samples labeled with a human alginate-specific monoclonal antibody F429 conjugated to 
Alexa Fluor 488 at 5.2 µg/mL. After incubation, samples were washed 3× with PBS and further incubated 
for 1 and 2 hours, at RT with, respectively, a secondary donkey anti-goat IgG conjugated to Alexa Fluor 
568 (Invitrogen, NY USA) diluted 1:250 in PBS 0.5% BSA, and the nucleic acid stain Syto 83 (5mM) 
(Invitrogen) at a final concentration of 5 µM. Samples were washed twice with PBS, and mounted with 
Mowiol mounting media and a glass coverslip. Slides were observed with a Zeiss LSM 5 Pascal confocal 
inverted microscope (Oberkochen, Germany) equipped with an Argon 488 nm laser, a HeNe1 543 nm 
laser, and a HeNe2 633 nm laser. Samples were viewed with a Plan Apochromat 63×/1.4 oil objective and 
data analyzed with Zeiss LSM Imaging software.  
 
Quantitative PCR  
Quantitative PCR (qPCR) analysis was performed as described in Chapter 2 with minor alterations. In 
brief, total RNA was reverse transcribed into complementary (c) DNA using the iScriptTM cDNA sysnthesis 
kit (Bio-Rad). The primers used for qPCR experiments were designed using Primer3 software [17] having 
S. epidermidis RP62A complete genome (PubMed accession number NC_002976.3) or ATCC 12228 (for 
psmβ, PubMed accession number NC_004461.1) as a template (Table 4.1). The run was performed using 
CFX96TM thermal cycler (Bio-Rad) with the following cycling parameters: 10 minutes at 95oC followed by 
40 repeats of 5 seconds at 95oC, 10 seconds at 60oC and 20 seconds at 72oC, using 5 µL of iQTM SYBR 
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Green Supermix (Bio-Rad), 0.5 µL of each forward and reverse primers at 10 µM, 2 µL of ultrapure water, 
and finally, 2 µL of 1:100 diluted cDNA. The data analysis was based on 3 independent experiments. 
 
Table 4.1. Oligonucleotide sequence of the primers used in this study. Bp-base pair. 
 
 
 
 
 
 
 
 
 
Antibiotic susceptibility 
The antibiotics and respective concentrations used in this study were: 40 mg/L of the cell wall synthesis 
inhibitor vancomycin (Sigma), 16 mg/L of the protein inhibitor tetracycline (Research Products 
International Corp., IL, USA), and 10 mg/L of the DNA-dependent RNA polymerase enzyme inhibitor 
rifampin (Fisher Scientific). The antibiotic concentration used was the peak serum concentration 
determined for each antibiotic [17]. Briefly, the different S. epidermidis populations were collected and 
processed as described above. A dilution was made in TSB in order to obtain an OD640nm of 0.4 that 
corresponds to 3 × 108 Colony Forming Units (CFU)/mL, and then diluted 10× in order to obtain 
approximately 3 × 107 CFU/mL. Afterwards, these suspensions were diluted 1:2 in fresh TSB containing 
each antibiotic and allowed to grow up to 6 hours at 37oC and 120 rpm. A control was obtained by 
diluting the suspension in fresh TSB without adding antibiotic. One mL of each sample was collected after 
2 and 6 hours of incubation, centrifuged for 10 minutes at 16000 g and 4oC, the pellet washed twice, and 
finally suspended into 1 mL of PSB 0.05% Tween20 (PSBT) (Boston BioProducts). These suspensions were 
sonicated for 15 seconds at 7 Watt and then vortexed at maximum speed for 10 seconds. The number of 
viable cells upon antibiotic exposure were quantified by performing 10-fold serial dilutions in PBST and 
Target gene  Primers sequence (5’ to 3’) TM (
oC) Amplicon size (bp) 
16S 
FW GGGCTACACACGTGCTACAA 59.79 
176 
RV GTACAAGACCCGGGAACGTA 59.85 
icaA 
FW TGCACTCAATGAGGGAATCA 60.20 
134 
RV TAACTGCGCCTAATTTTGGATT 59.99 
atlE 
FW GTAGATGTTGTGCCCCAAGG 60.38 
180 
RV TGGAAGAGGAACAGTTTGGAC 59.17 
psm 
FW AGCAGAAGCTATTGCAAATACAG 57.96 
105 
RV CCTAATACGCTAACGCCACTTT 59.72 
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plated onto TrypticaseTM Soy Agar 5% sheep blood (TSAsb) plates (Becton Dickinson, NJ, USA). Plates 
were incubated for 48 hours at 37 °C. This experiment was repeated at least 5 times.  
 
Normal human serum collection  
Fresh human blood was collected from healthy adult volunteers under the 1999-P-001173/48 (BWH 
Legacy #: 84-01009) protocol approved by the Partner’s Health Care System Institutional Review Board 
(Boston, MA, USA). All donors gave written informed consent to have blood taken. Blood was then 
transferred to BD Vacutainer® tubes (Becton Dickinson) and centrifuged at 13000 g and 4oC for 30 
minutes. Normal human serum (NHS) was then collected and stored at -80oC until further use.  
 
Initial adhesion quantification 
The initial adhesion ability of the biofilm-released cells comparatively to their planktonic and biofilm 
counterparts was determined using abiotic surfaces and assessed over the time, as described before 
[18]. Sterile acrylic (2 × 2 cm) and silicone (2 × 2 cm) surfaces were placed onto 6-well tissue culture plate 
(Orange Scientific), and covered with 4 mL of each bacterial suspension at 1 × 107 CFU/mL. In the case of 
glass surfaces (Ø1cm), these were placed into 24-well tissue culture plate and covered with 0.3 mL of 
each bacterial suspension at the same concentration. In order to determine the effect of surface coating 
by host matrix proteins in the adhesion of the biofilm-released cells, glass surfaces were incubated with 
NHS. In brief, sterile glass surfaces were covered with 0.1 mL of 10% NHS diluted in PBS, and incubated 
for 15 minutes at RT [19]. The surfaces were then washed twice with PBS to remove unbound proteins. 
Coated or uncoated surfaces were incubated for 10, 30 or 60 minutes at 37oC and 120 rpm. After 
incubation, the surfaces were washed twice in PBS to remove non-adhered cells and stained, for 10 
minutes, with 2.5 µg/mL of 4,6-diamino-2-phenylindole (DAPI). The adhered cells were observed under 
an Olympus BX51 epifluorescent microscope equipped with a CCD color camera DP71 (OLYMPUS,PA, 
USA) which acquires images with 1360 × 1024 pixel resolution at a magnification of 200×. For each 
surface, at least 10 TIFF images were taken randomly over the entire surface. The enumeration of the 
adhered cells per cm2 of surface was determined using the image analysis automated enumeration 
software (SigmaScan Pro 5.0, Systat Software, Sigma). In these conditions, 18420 ± 1575 pixels were 
equivalent to 0.0025 cm2 [20]. The experiment was repeated at least twice and with 2 technical 
replicates.  
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Opsonophagocytic killing assay  
Opsonophagocytic killing assays were performed as described elsewhere [21], with some minor 
alterations. The Human promyelocytic leukemia cell line HL-60 (American Type Culture Collection, VA, 
USA) was differentiated into neutrophils in the presence of 0.8% of dimethylformamide (Sigma) for 5 to 
6 days at 37oC and 5% CO2. Using trypan blue staining (Sigma), to differentiate dead from live cells, the 
final HL-60 count was adjusted to 1 × 108 cells/mL. Bacterial suspensions of each S. epidermidis 
populations were adjusted with TSB to 3 × 108 CFU/mL and serial diluted in order to obtain 1 × 106 
CFU/mL. NHS was used at concentration of 10%. All the dilutions were performed in Roswell Park 
Memorial Institute (RPMI) (Gibco, NY, USA) supplemented with 1% bovine serum albumin (American 
BioAnalytical, MA, USA) and 10 mM of HEPES (Gibco) (designed as complete RPMI). In Brief, the assay 
mixture contained 100 µL of HL-60 (at a concentration of 1x108 cells/mL), 100 µL of each bacterial 
suspension (at a concentration of 1×106 CFU/mL), 100 µL of a 10% NHS and 100 µL of complete RPMI. 
Tubes with bacteria only, bacteria plus HL-60, and bacteria plus 10% NHS were used as controls and for 
validation of the assay. The reaction mixture was incubated on a rotor rack at 37°C for 90 min. After 
incubation, the tubes were sonicated for 10 seconds at 7 Watt followed by 10 seconds vortex at 
maximum speed. The suspensions were serial diluted in PSBT and plated onto BBL™ Trypticase™ Soy 
Agar with 5% Sheep Blood (TSA II) (Becton Dickinson). The percentage of the surviving bacteria was 
calculated by determining the ratio of the CFU/mL surviving in the test tubes and the control tube with 
bacteria only. This experiment was performed three independent times with technical triplicates.  
 
Mice  
Female BALB/c mice were purchased from Charles River (Barcelona, Spain) and kept under specific-
pathogen-free conditions at the Animal Facility of the Instituto de Ciências Biomédicas Abel Salazar, 
Porto, Portugal. All procedures involving mice were performed according to the European Convention for 
the Protection of Vertebrate Animals used for Experimental and Other Scientific Purposes (ETS 123), the 
86/609/EEC directive, and Portuguese rules (DL 129/92). 
 
Challenge infections 
The bacterial inocula of the different S. epidermidis populations were adjusted to 5 × 108 cells/mL in a 
flow cytometer using counting beads and SYBR Green I /propidium iodide staining to differentiate 
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between live and dead bacteria, as described previously [12]. Female BALB/c with 8-10 weeks were 
injected intravenously (i.v.) in the lateral tail vein with 1 × 108 of planktonic, biofilm or biofilm-released 
cells in 0.2 mL PBS. Control mice were injected with 0.2 mL of PBS. Each challenge was then confirmed by 
plating the inoculum in TrypticaseTM Soy Agar plates (TSA, Becton Dickinson). 
 
Bacterial dissemination assessment 
Two, 6 and 14 hours post-infection, liver and spleen were aseptically removed, homogenized 
mechanically in 3 mL of PBS, and quantitatively cultured on TSA plates (Bencton Dickinson). Plates were 
then incubated at 37°C for approximately 20 hours.  
 
Cytokine/ chemokine quantification 
Interleukin (IL)-6 (eBioscience, CA, USA) and the chemokines KC (CXCL1) and MCP-1 (CCL2) (R&D 
DuoSet®, MN, USA) were quantified following the manufacturer’s instructions.  
 
Statistical analysis 
Statistical significance between groups was evaluated by either one-way ANOVA with Tukey’s multiple-
comparisons test or two-way ANOVA with Bonferroni post test. Percentage values were previously 
transformed to arcsin and then analyzed by the appropriated statistical analysis test. All tests were 
performed with the GraphPad Prism version 5 (GraphPad Software, CA, USA). Differences between 
groups were considered significant when p<0.05.  
 
 
RESULTS AND DISCUSSION 
The total protein profile of biofilm-released cells resembles biofilm phenotype  
The evaluation of the total protein profile is one quick method to assess genotypic and phenotypic 
differences between bacterial populations. By using this approach, we could observe that S. epidermidis 
biofilm-released cells present more similarities to biofilm than to their planktonic cell counterparts 
(Figure 4.2). The more evident differences/similarities were detected in protein bands with apparent 
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molecular mass between 14 and 3 kDa. Besides the clear qualitative differences, these small protein 
bands are present in higher amounts in biofilm-released than in planktonic or even biofilm cell extracts. 
Moreover, biofilm-released cells present a unique protein band with approximately 14 kDa. In order to 
correlate this unique protein with possible higher or lower virulence potential, a bioinformatics analysis 
using ExPASy, TagIdentTool [22], based in the molecular weight of the protein was performed. 
 
 
 
Figure 4.2. Total protein profile of S. epidermidis populations. Protein band migration profile of total protein cell 
extracts obtained from planktonic (P), biofilm (B) or biofilm-released cells (Brc) using lysostaphin digestion. Samples 
were loaded (30 µg protein/lane) into 4-12% Bis-Tris gel that was stained using Bio-Rad silver stain. (A) 5 minutes, 
(B) 15 minutes of developing process. The row indicates the unique protein presented in the biofilm-released cells 
and the square the group of proteins with clear qualitative and quantitative differences between the populations.  
 
This analysis suggested that this protein belongs to a group of ribosomal proteins involved in translation 
or rRNA and tRNA processing, toxin-antitoxin module, holin-like protein, glycine cleave system H, 
Initiation-control protein YabA, protein ArsC or VraC, ribosome-binding factor A. The protein may also 
belong to a group of uncharacterized proteins. However, due to the high number of possible functions, 
the isolation and identification of this protein should be done in the future, as it may be a possible target 
of anti-microbial strategies to be used against the infections developed by disassembled cells.  
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The expression of biofilm-related genes presented by biofilm-released cells is shared with their 
planktonic and biofilm counterparts  
To determine the involvement of S. epidermidis biofilm lifecycle-associated genes in the phenotype of 
the biofilm-released cells and evasion from the immune system, we have quantified the expression of 
the autolysin atlE, that mediates the adhesion to biotic and abiotic surfaces, as well as cell lyses and 
consequent release of DNA that acts as adhesive molecule [23,24]; icaA, that encodes one of the 
enzymes involved in PNAG synthesis, which is a key molecule in biofilm accumulation [25] and immune 
evasion [21,26,27]; psmβ that is involved in biofilm disassembly [1,6] and, finally, rsbU, a positive 
regulator of biofilm formation [28,29]. As shown in Figure 4.3, significant differences in genetic 
expression were found between the populations.  
 
 
 
Figure 4.3. Expression of genes involved in S. epidermidis biofilm lifecycle. Normalized expression values were 
calculated using 16 rRNA ribosomal subunit by applying the 2
ΔCt
 mathematical model. The bars represent mean plus 
or minus standard error of the mean of 3 independent experiments. Statistical differences between groups were 
analyzed with one-way ANOVA and Tukey’s multiple comparisons test. p<0.05 when comparing biofilm-released 
with biofilm phenotype.  
 
When analyzing biofilm-released cells gene expression profile, we observed, in the case of the psmβ, that 
these cells produce as much modulin as their planktonic counterparts, both twice as more as biofilm-
derived cells (Figure 4.3). In accordance with our results, Wang and his collaborators (2011) have shown 
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that cells in the effluent of biofilm cultures expressed higher levels of psmβ suggesting that psmβ 
expression leads to biofilm cluster disassembly during biofilm development. This indicates that in our 
study bacteria were released from the biofilm through an active mechanism of disassembly [1]. Using a 
foreign body infection mice model, it was shown that psmβ play an essential role in biofilm virulence, 
since biofilm formed by S. epidermidis psmβ isogenic mutant on the surface of catheters, presented less 
ability to disseminate into the host organs [1]. In the case of atlE and rsbU expression, biofilm-released 
cells clearly resemble the biofilm cells, while in the case if icaA gene expression, biofilm-released cells 
display the same trend as planktonic cells, even though no statistically significant differences were 
found.  
 
Biofilm-released cells, present lower amount of PNAG on the surface 
PNAG is known to be involved in both biofilm accumulation [25] and immune evasion [21,26,27]. 
Therefore, higher or lower amounts of PNAG on the bacterial surface can affect virulence. When cells are 
released from the biofilm they are more exposed to host immune effectors. In this situation, the PNAG 
attached to the bacterial surface is crucial for protection against the action of antimicrobial peptides 
(AMPs) [30,31], and the deposition of antibodies and complement factors that will help the phagocytic 
process [26]. CLSM was thus performed to assess the presence or absence of PNAG on the surface of 
biofilm-released cells. Although CLSM analysis was used as a qualitative tool, it was able to show 
interesting differences between populations (Figure 4.4). Using the monoclonal antibody anti-PNAG, 
mAb F598, we were able to visualize that both biofilm-released (Figure 4.4 C1) and planktonic cells 
(Figure 4.4 A1) present only basal levels of PNAG. However, it is clear that biofilm cells present higher 
distribution of the PNAG on their surface (Figure 4.4 B1), which may suggest less susceptibility to 
phagocytosis and AMPs. As shown in the Figure 4.4 panel 4, corresponding to the control sample, no 
cross reactivity was observed when the different S. epidermidis populations were incubated with a mAb 
specific for the alginate capsule of Pseudomonas aeruginosa.  
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Figure 4.4. Confocal Laser Scanning Microscopy imaging of PNAG expression on the surface of planktonic (A), 
biofilm (B) and biofilm-released (C) cells. S. epidermidis cells were labeled with either mAb F598 to PNAG or mAb 
F429 to alginate, both conjugated to Alexa Fluor 488 (green). The panels 1 and 3 represent the binding of the 
nucleic acid stain SYTO 83 (red). The panel 2 represents the binding of the mAb F598 and the panel 4 the binding of 
the control mAb F429. Bar = 10 µm. 
 
Biofilm-released cells show higher tolerance to tetracycline than planktonic growing cells 
Considering the known differences in antibiotic susceptibility between planktonic and biofilm cultures, 
we have tested the antibiotic susceptibility of biofilm-released cells to peak serum concentrations of 
rifampin, tetracycline and vancomycin (Figure 4.5) [17]. The delta log10 CFUs/mL unit-reduction values 
presented 2 and 6 hours after exposure to antibiotics were calculated relatively to time zero. 
Interestingly, 2 and 6 hours after exposure to tetracycline, we observed that biofilm-released cells 
presented significant higher tolerance to tetracycline than their planktonic counterparts, showing only a 
0.7 log10 CFU/mL unit-reduction versus the 2.2 log10 CFU/mL unit-reduction presented by planktonic 
cells. Six hours post-exposure, biofilm-released cells showed 1.7 log10 CFU/mL unit-reduction against the 
2.5 log10 CFU/mL unit-reduction showed by planktonic cells.  
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Figure 4.5. Base 10 logarithmic CFU/mL unit-reduction of S. epidermidis populations upon incubation with 
antibiotics. The 3 different populations were incubated for 2 and 6 hours with peak serum concentrations of 
rifampin, vancomycin and tetracycline. The columns represent the mean plus or minus standard error of the mean 
of 5 to 6 independent experiments. Statistical differences between groups were analyzed with two-way ANOVA 
and Bonferroni post test. ** p<0.01; ***p<0.001 when comparing biofilm-released with their planktonic 
counterparts. P-planktonic; B-biofilm; Brc-biofilm-released cells. 
 
These results were different from what was shown previously for Staphylococcus aureus [32], where 
biofilm-released cells were as sensitive as planktonic cells to rifampin. Nevertheless, similar to our 
results, cell released from Streptocccus mutans biofilms showed to be more resistant to chlorhexidine 
than their planktonic counterparts [10]. The enhanced tolerance presented by the cells released from 
biofilms over their planktonic counterparts may have an important impact in the efficacy of both 
prophylactic and therapeutic approaches that do not account with this fact, leading to the decrease of its 
efficiency. Although this analysis have provided important insights in the tolerance of the biofilm-
released cells to a representative group of antibiotics (cell wall, protein and RNA synthesis inhibitors), an 
array of different antibiotics should be tested in order to better understand the tolerance presented by 
these cells, and its consequence in the virulence of S. epidermidis biofilm-related infections.  
 
Biofilm-released cells do not adhere better to abiotic surfaces than biofilm or planktonic cells  
Taking into consideration the hypothesis that biofilm-released cells present higher potential to colonize 
other regions of the host, we assessed the initial adhesion ability of the 3 populations to different abiotic 
surfaces, uncoated (acrylic, glass and silicone) or coated (glass surfaces) with human serum proteins. The 
number of adhered cells per cm2 of surface is presented in the Figure 4.6. Planktonic, biofilm and biofilm-
released cells presented similar ability to adhere to any of the uncoated abiotic surfaces tested, 
independently of its hydrophobicity, a parameter known to affect initial adhesion [18]. 
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Figure 4.6. Number of base 10 logarithmic S. epidermidis cells adhered per cm
2
 of silicone, acrylic and glass 
surfaces. The bars represent the average plus or minus the standard error of the mean of 3 independent 
experiments. Statistical differences between groups were analyzed with two-way ANOVA with Bonferroni post test. 
P-planktonic; B-biofilm; Brc-biofilm-released cells. 
 
Additionally, in order to verify if a conditioning film composed of human serum proteins could provide an 
advantage for bacterial initial adhesion, glass surfaces were coated with 10% NHS and incubated with 
each bacterial suspension for 30 minutes. However, despite influencing the overall adhesion ability 
shown by all the populations, no significant differences were found between the 3 populations 
adherence to coated surface (Figure 4.7). 
 
 
Figure 4.7. Number of base 10 logarithmic S. epidermidis cells adhered per cm
2
 glass coated surface upon 30 
minutes of incubation. The bars represent the mean plus and minus the standard error of the mean of 3 
independent experiments. Statistical differences between groups were analyzed with one-way ANOVA with Tukey’s 
multiple comparison test. P-planktonic; B-biofilm; Brc-biofilm-released cells. 
 
Clearly all the populations present the same ability to adhere to both coated and uncoated surfaces, 
indicating no advantage of biofilm-released cells over the other phenotypes to adhere. Since initial 
adhesion studies are highly variable depending on the testing conditions, [33], we repeated the 
experiment with two more different initial inocula concentration (1 × 105 and 4 × 107), and two different 
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adhesion times (10 and 180 min). Again, no differences between the 3 populations were found (data not 
shown). However, we cannot rule out that different conditions could provide different results. 
 
Biofilm-released cells are as sensitive to oposonophagocytic killing as planktonic cells 
It was previously shown that biofilm cells are more resistant to oposonophagocytic killing than their 
planktonic counterparts [21]. Hence, we aimed to further assess possible differences in virulence 
potential of biofilm-released cells using an in vitro opsonophagocytic killing assay. The percentage of 
surviving CFU/mL of each population upon incubation with 10% NHS and the human promyelocytic 
leukemia cell line HL-60 was compared with CFU/mL obtained in tubes containing bacteria only. The 
other controls performed, bacteria plus 10% NHS or plus HL-60, showed no unspecific killing during the 
assay. As represented in Table 4.2, biofilm-released cells seem to be as sensitive as their planktonic 
counterparts to opsonophagocytic killing, when compared with biofilm cells, which presented, as 
expected, higher tolerance to the stress created by the presence of NHS and HL-60 cells. These results 
suggest that biofilm-released cells, as planktonic cells, may be less protected against opsonophagocytic 
killing than biofilms-derived cells, which is probably related to the lower contents of PNAG observed on 
the surface of these cells.  
 
Table 4.2. Opsonophagocytic susceptibility of the different S. epidermidis populations in the presence of 10% 
NHS and the human cell line HL-60. The percentage of surviving bacteria presented is relative to the control (only 
bacteria after 90 minutes of incubation at 37oC) plus and minus standard error of the mean. Statistical differences 
between groups were analyzed with two-way ANOVA with Bonferroni post test. p<0.01 when comparing biofilm-
released with biofilm cells. P-planktonic; B-biofilm; Brc-biofilm-released cells. 
 
 
Percentage of surviving bacteria 
P B Brc  
Bacteria + 10% NHS  136.43 ± 31 124.20 ± 11 124.66 ± 17 
Bacteria + HL-60  121.33 ± 14 112.50 ± 19 97.73 ± 13 
Bacteria + HL-60 + 10% NHS 17.00 ± 1.6 26.00 ± 2.6 13.00 ± 0.56 
 
Biofilm-released cells stimulate a unique response from the host immune system  
In order to explore the virulence of biofilm-released cells comparatively to their planktonic and biofilm 
counterparts, an intravenous mouse infection model was used. Bacterial dissemination into systemic 
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organs such as liver and spleen, and thus the ability to colonize and persist in the host was assessed 2, 6 
and 14 hours after infection (Figure 4.8). The overall results showed that irrespectively to the phenotype, 
S. epidermidis populations are quickly cleared from the host as observed by the decrease in CFU levels 
recovered over the time-course of infection. Analyzing in more detail the bacterial load in both the liver 
and spleen, it can be observed that biofilm-released cells, despite the differences found, present a 
colonization profile very similar to planktonic cells. However, with the time-course of infection is it clear 
that these cells become different from both planktonic and biofilm counterparts, showing an 
intermediary colonization and persistence pattern.  
 
 
 
Figure 4.8. Number of base 10 logarithmic CFU recovered from both liver and spleen of BALB/c mice infected i.v. 
with 1 × 108 cells of S. epidermis planktonic, biofilm and biofilm-released cells, 2, 6 or 14 hours post-challenge. 
Each dot represent the value of an individual animal and the longitudinal line the average of 1 (biofilms) to 3 
independent (planktonic and biofilm-released cells) experiments. Statistical differences between groups were 
analyzed with one-way ANOVA with Tukey’s multiple comparison test. P-planktonic; B-biofilm; Brc-biofilm-released 
cells. 
 
In addition to evaluate the colonization ability, we also aimed to assess if the different S. epidermidis 
populations could distinctly stimulate the host immune system, by quantifying the systemic signals of 
inflammation, and the activation and recruitment of macrophages and neutrophils, which are considered 
the ﬁrst line of defense against bacterial infection. To achieve that, the concentration of IL-6 and the 
MCP-1 and KC chemokines was determined in the serum of infected mice (Figure 4.9).  
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As can be observed, the challenge by all the S. epidermidis populations stimulated a significant increase 
in the production of IL-6, KC and MCP-1 when compared with the control (non-infected group).  
 
 
 
Figure 4.9. The level of the IL-6 (top) and the chemokines KC (middle) and MCP-1 (bottom) of BALB/c mice 
infected i.v. with 1 × 10
8
 cells of S. epidermis planktonic, biofilm and biofilm-released cells, 2, 6 or 14 hours post-
challenge. The bars represent the average plus or minus the standard error of the mean of 1 (biofilm-derived cells) 
to 3 independent experiments (planktonic and biofilm-released cells). Statistical differences between groups were 
analyzed with one-way ANOVA with Tukey’s multiple comparison test. *p<0.05; **p<0.01; ***p<0.0001 when 
comparing all the S. epidermidis populations with the control PBS or when comparing biofilm-released cells with 
their planktonic counterparts. p<0.05 when comparing biofilm-released with biofilm phenotype. PBS-phosphate 
buffered saline; P-planktonic; B-biofilm; Brc-biofilm-released cells.  
 
However, over the time-course of the infection some particularities associated with S. epidermidis 
biofilm-released cells were observed. Despite similar levels of IL-6 were induced by any of the 
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populations, a significantly higher IL-6 concentration was detected 2 hours after the i.v. challenge, in the 
sera of mice infected with biofilm-released cells comparatively to their planktonic counterparts. 
However, 6 and 14 hours post-infection, similar levels of IL-6 to those observed in their biofilm 
counterparts were detected, both lower than those detected in the sera of planktonic-infected mice. As 
shown in Figure 4.9, biofilm-released cells stimulated a higher production of KC than the planktonic 
population as detected 2 hours post-infection. However, 6 and 14 hours post challenge, mice infected 
with planktonic cells reached the same stimulation levels as mice infected with biofilm-released cells, 
both presenting higher levels of KC than biofilm-derived cells. Interestingly, no significant differences in 
the serum levels of the monocyte chemoattractant MCP-1 were observed between mice infected with 
either of the three S. epidermidis populations used. These results, altogether, show that biofilm-released 
cells present features distinct from the other known phenotypes. However, although these results 
provide interesting and important insights into the virulence of biofilm-released cells, a more detailed 
study is needed to better understand the persistence in the host organs, as well as the type of immune 
response elicited by biofilm-released cells and hence, its implications in S. epidermidis biofilm infection 
virulence.  
 
 
CONCLUSIONS 
The characterization of phenotypic features, as well as the characterization of the biofilm-released cells 
interaction with the host immune system, is of crucial importance to prevent the serious pathologic 
events associated with the biofilm cells dissemination. Therefore, by characterizing S. epidermidis 
biofilm-released cells virulence through several important parameters, we were able to advance the 
knowledge on this topic. Under our experimental conditions, S. epidermidis biofilm-released cells present 
different phenotypic features than the ones presented by either biofilm or planktonic cells, with an 
impact in their virulence potential. The most striking difference observed between the populations is the 
increased resistance to tetracycline shown by S. epidermidis biofilm-released cells. This resistance may 
have important consequences in the efficacy of prophylactic and therapeutic measures based in 
antibiotics that act in protein synthesis blockage, since the resistance observed seem to be related with 
the mechanism of action of the antibiotic. Although some authors claim that these cells will ultimately 
revert to the planktonic phenotype, more studies are needed to clarify that possibility. Furthermore, 
even if at longer time periods the disassembled cells would eventually reverted completely to the 
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planktonic phenotype, the result of this transient phenotype in virulence and bacterial survival should 
not be neglected. 
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CHAPTER 5. 
 
The use of anti-PNAG antibodies to inhibit S. 
epidermidis biofilms accumulation in vitro 
 
 
 
ABSTRACT  
Due to broad-spectrum antibiotics tolerance of bacteria within biofilms, the 
use of antibodies have been shown to be one promising alternative to target 
surface-attached molecules and inhibit biofilm formation. Because S. 
epidermidis biofilm accumulation is mainly mediated by PNAG, we have tested 
the ability of previously produced polyclonal or monoclonal antibodies anti-
PNAG to inhibit S. epidermidis biofilm accumulation in vitro, using the standard 
crystal violet staining. Although the polyclonal antibodies 9GlucNH2-TT and 
dPNAG-TT did reduce the biofilm accumulation in vitro, the control normal 
rabbit serum presented the same pattern of inhibition, indicating the presence 
of other factors in the serum able to inhibit biofilm accumulation in a PNAG-
independent manner. In the case of the monoclonal antibody F598, the effect 
observed was clearly PNAG-dependent. However, depending on the S. 
epidermidis strain used, the monoclonal antibody F598 had differential effect, 
resulting in an inhibition or enhancement  of the biofilm accumulation in vitro. 
Hence, this work have shown, that serum may present factors that effectively 
inhibit S. epidermidis biofilm accumulation and, on the other hand, that 
monoclonal antibodies should be tested in several strains in order to ensure 
that the pretended effect is transversal to several strains.  
 
 
 
Part of the work described in this chapter was published in International 
Journal of Biological Sciences 2013, 9(5):518-20. 
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BACKGROUND  
Due to the ability of S. epidermidis to form biofilms on the surface of indwelling medical devices, these 
devices are a common source of serious biofilm-related infections [1]. Since S. epidermidis biofilms are 
highly tolerant to antibiotics [2] and to the host immune system effectors [3], the surgical removal of the 
infected devices is often required to resolve those infections [4] resulting in significant effects in a 
patient’s quality of life, as well as an heavy burden to the public health system [5]. Hence, preventive 
approaches are clearly needed to overcome this challenge. Due to broad-spectrum antibiotics tolerance 
of bacteria within biofilms, among others, the use of antibodies have been shown to be one promising 
alternative to target surface-attached molecules and inhibit biofilm formation [6-8]. Since in most clinical 
S. epidermidis strains biofilm accumulation is mainly mediated by the polysaccharide poly-β-1,6-N-
acetylglucosamine (PNAG) [9,10], it was hypothesized that the binding of this molecule by monoclonal or 
polyclonal antibodies anti-PNAG could impact biofilm accumulation. It was previously shown that human 
monoclonal antibodies (mAbs) and rabbit polyclonal antibodies (pAbs), specific for PNAG, were effective 
in killing S. epidermidis as well as other PNAG-producing bacteria in opsonophagocytic in vitro assays 
[3,11,12], and in protecting the murine host against these infections [13-15]. Nevertheless, the efficacy 
of these antibodies in inhibiting S. epidermidis biofilm formation in vitro has not previously been 
investigated. Hence, in this chapter, we describe the effectiveness of previously synthesized and 
characterized pAbs 9GlucNH2-TT and dPNAG-TT, and mAb F598 to inhibit S. epidermidis biofilm 
accumulation in vitro.  
 
 
MATERIALS AND METHODS 
Bacteria and growth conditions 
S. epidermidis RP62A, 1457, 1457-M10 and M184 were used in this work. One single colony of each 
strain was transferred from TrypticaseTM Soy Agar 5% sheep blood (TSAsb) plates (Becton Dickinson, NJ, 
USA), not older than 2 days, into 2 mL of Tryptic Soy Broth (TSB) (Becton Dickinson), and incubated 
overnight at 37oC and 700 rpm (VorTempTM, Labnet International, NJ, USA). The overnight culture was 
then diluted 1:100 in fresh TSB for further experiments.  
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Polyclonal antibodies  
The previous developed and synthesized pAbs raised against both naturally occurring and further de-
acetylated PNAG (dPNAG) [16], and synthetic oligosaccharide of 9 monosaccharide units (9Glc-NH2) [17], 
both conjugated with tetanus toxoid (TT) were used. Briefly, these antibodies were obtained by 
subcutaneous immunization of New Zealand White rabbits with 100 μg (dPNAG-TT) or 10-μg doses 
(9GlucNH2-TT) of the polysaccharide emulsified in incomplete Freund's adjuvant. One week later the 
rabbits were injected intravenously, three times, with the antigen in saline solution, each injection 
spaced by 3 days. Rabbits were bled every 2 to 6 weeks, and serum was tested by ELISA using purified 
PNAG as the coating antigen [13]. Normal rabbit serum (NRS), previously tested for anti-PNAG 
immunoglobulin (Ig) contents, was used as a control.  
 
Monoclonal antibodies  
The previously developed and synthesized monoclonal antibody (mAb) IgG1 F598 raised against PNAG 
[15] was used. In brief, B cells from a patient recovering from Staphylococcus aureus infection were 
transformed with Epstein-Barr virus and screened for their ability to bind either acetylated or de-
acetylated PNAG. Ig variable region genes from hybridomas of interest were cloned into the IgG1-TCAE6 
vector and transfected into CHO cells for the production of fully human IgG1 mAbs [15]. The mAb F429 
raised against Pseudomonas aeruginosa alginate capsule was used as an isotype control and was 
developed and synthesized as described elsewhere [18]. 
 
Removal of endogenous immunoglobulin and inactivation of endogenous complement factors in 
polyclonal antibodies  
Endogenous Ig present in both pAbs were removed by adsorption with a PNAG-negative strain, S. 
epidermidis 1457-M10 [19]. NRS was absorbed as well, however, using a PNAG-positive strain, S. 
epidermidis 1457, in order to remove both endogenous Ig and possible naturally occurring antibodies 
anti-PNAG. In brief, NRS and both pAbs were diluted 10 × in Minimum Essential Media (Gibco, NY, USA) 
supplemented with 1 % bovine serum albumin (Sigma, MO, USA) and incubated with bacterial 
suspension with an OD640nm=1 for 30 minutes at 4
oC with constant rocking. After incubation, bacteria 
were removed by 10 minutes centrifugation at 4oC and 16000 g. This procedure was repeated three 
times. Finally, in order to inactivate endogenous complement factors, both NRS and polyclonal 
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antibodies were incubated for 30 minutes at 56oC, and filtered through a Spin-X® Centrifuge tube with a 
0.22 µm pore (Corning®Costar, NL, Mexico) to eliminate any remaining bacteria.  
 
Biofilm inhibition assays using polyclonal antibodies  
In order to test the ability of both dPNAG-TT and 9GlucNH2-TT to inhibit biofilm accumulation, an 
overnight culture of S. epidermidis RP62A was diluted 1:100 in TSB, and 150 µL of this suspension 
distributed into 96-well tissue culture plates (Corning®Costar). Subsequently, absorbed and heat-
inactivated pAbs or NRS were added to the appropriated wells, starting with 1:100 dilution and 
performing serial 2× fold dilutions until obtaining a 1:3200 dilution. The plates were then incubated 
statically at 37oC, for 1 hour, to allow antibody binding to the bacterium, and then placed at 250 rpm for 
24 hours. The experiment was repeated twice and each pAb and NRS concentration evaluated in 
quadruplicates.  
 
Biofilm inhibition assays using monoclonal antibody 
In order to evaluate the ability of mAb F598 to inhibit S. epidermidis biofilm accumulation, overnight 
cultures of S. epidermidis RP62A, 1457, 1457-M10 and M184 were diluted and distributed as described 
for pAbs assays. Subsequently, 150 µL of the mAbs F598 or F429 previously diluted were added to the 
bacterial culture in order to obtain 333, 167, 67 and 6.7 nM of antibody in each appropriated wells. The 
plates were incubated, statically, at 37oC for 1 hour to allow antibody binding, and then incubated at 250 
rpm, 37oC for 24 hour. The experiment was repeated twice and each mAb concentration evaluated in 
quadruplicates. 
 
Biofilm quantification  
Crystal violet staining was performed after 24 hours of co-culture of bacteria and either mAbs or pAbs in 
order to assess the S. epidermidis biofilm accumulation in the different conditions. The medium was 
removed and the biofilms were washed three times with PBS (Boston BioProducts). Microtiter plates 
(Costar®Corning) were then incubated at 37oC in an inverted position for approximately 2 hours to dry 
the biomass. Biofilms were then stained with 0.5% crystal violet (w/v) (Sigma) (dissolved in water) for 15 
minutes at room temperature, washed 5 × with tap water, and then the plates were incubated in an 
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inverted position for a few seconds. Finally, crystal violet was dissolved with 200 µL of 33% acetic acid 
(v/v) (Fisher Scientific), and the absorbance was recorded at 595 nm in an ELISA microtiter reader 
(BioTek Instruments, VT, USA).  
 
Statistical analysis 
Statistical significance between groups was evaluated by either Kruskal-Wallis one-way ANOVA and 
Dunn’s multiple comparisons test or Dunnett’s multiple comparisons test, both with a 95% confidence 
level. Differences between groups were considered significant when p<0.05. Statistical analysis was 
carried out with GraphPad Prism version 5 (CA, USA).  
 
 
RESULTS AND DISCUSSION  
Polyclonal anti-PNAG antibodies inhibits S. epidermidis biofilm accumulation in vitro through a PNAG-
independent mechanism 
Because pAbs are produce by different B cells after encounter the antigen, they present different 
affinities, and therefore, different ability to recognize and bind to multiple epitopes. Having this into 
account, pAbs present a higher chance to more effectively bind to PNAG and thus inhibit cell-cell 
interaction and consequent biofilm accumulation. For this reason, we tested the ability of both dPNAG-
TT and 9Gluc-NH2-TT to impair S. epidermidis biofilm accumulation in vitro.  
As show in the Figure 5.1, although biofilm accumulation was highly inhibited by both 9Gluc-NH2-TT and 
dPNAG-TT, the NRS control did have similar effect on S. epidermidis RP62A biofilm accumulation. This 
may indicate the presence of endogenous anti-PNAG antibodies or other endogenous Ig in the serum 
and in the antiserum, respectively, that could be influencing biofilm accumulation.  
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Figure 5.1. Effect of both 9Gluc-NH2-TT and dPNAG-TT pAbs, and the control NRS on S. epidermidis biofilm 
accumulation in vitro. The bars represent the median with interquartil range of two independent experiments with 
quadruplicates for each concentration tested. Statistical significance was analyzed one-way ANOVA test and Dunn’s 
multiple comparisons test with a 95% confidence level. * p<0.05, **p<0.01; ***p<0.001 vs. 0 (TSB). NRS-normal 
rabbit serum; OD-optical density. 
 
Thus, in order to remove these endogenous factors, both pAbs and NRS were absorbed with S. 
epidermidis PNAG-negative 1457-M10 or PNAG-positive strain 1457, respectively. Nevertheless, in both 
cases, no significant differences were found before and after the absorption showing that the 
mechanism by which the biofilm accumulation is being impaired is not PNAG-dependent (Figure 5.2).  
Despite PNAG importance in biofilm formation and accumulation in S. epidermidis, it was shown that 
clinical isolates that do not produce PNAG can still form biofilms [20], indicating the involvement of other 
adhesive factors in biofilm accumulation. Indeed, in the last years, it has been shown the involvement of 
several proteins in S. epidermidis biofilm accumulation such as Aap [21], Bhp [14], Embp [22], SesC [7].  
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Figure 5.2. Effect of both 9Gluc-NH2-TT and dPNAG-TT polyclonal antibodies as well as NRS in S. epidermidis 
biofilm accumulation in vitro after absorption. The bars represent the median with interquartil range of 3 
technical replicates for each concentration tested. Statistical significance was analyzed by one-way ANOVA test and 
Dunnett’s multiple comparisons test with a 95% confidence level. * p<0.05, **p<0.01; ***p<0.001 vs. 0 (TSB). NRS-
normal rabbit serum; OD-optical density. 
 
Rabbit serum presents several proteases in its composition [23] which may be involved in the 
degradation of adhesive proteins and thus decrease S. epidermidis biofilm accumulation. On the other 
hand, because both pAbs and NRS were heat-inactivated, the possible involvement of complement 
proteins in biofilm accumulation impairment was discarded. Although we did not further characterize 
the involvement of possible proteases in the inhibition caused by the NRS, in S. aureus, it has been 
shown that normal human serum was able to inhibit biofilm formation [24,25], however, the factor that 
was mediating the inhibition was not proteinaceous [24]. Another hypothesis that could explain the 
biofilm formation inhibition in the presence of serum is its slightly alkaline pH, that can negatively 
influence biofilm formation [26]. Abraham and Jefferson [24] have shown that normal human serum, 
even buffered was still able to cause inhibition of S. aureus biofilm accumulation in vitro. Hence, further 
studies are needed to uncover the factors present in the serum that play a role in the inhibition of 
biofilm accumulation in vitro which later may help to understand biofilm formation in vivo.  
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Monoclonal antibody raised against PNAG has variable effects on S. epidermidis biofilm accumulation 
in vitro  
Serum is complex milieu that harvest several molecules and factors of the host immune system. Hence, 
besides the possible endogenous Ig and natural occurring anti-PNAG antibodies, there are several 
protein and non-protein factors that may impact S. epidermidis biofilm accumulation, as we observed in 
the assays performed with NRS. Therefore, we have tested the ability of highly specific mAbs  to impair S. 
epidermidis biofilm accumulation in vitro. Therefore, we have used an already characterized anti-PNAG 
mAb, IgG1 F598, which presents high affinity for both acetylated and deacetylated forms of PNAG [15]. 
As an isotype negative control, the monoclonal antibody IgG1 F429 produced against P. aeruginosa 
capsule was used [18].  
As expected, the mAb F598 presented a doses-dependent effect in biofilm accumulation, while the mAb 
F429 control had no significant effect. Additionally, in the case of the PNAG-deficient, ica-mutant strain 
1457-M10, no significant effect was found on the biofilm biomass as no PNAG is produced. Hence, these 
results suggest that the effect caused by the presence of the mAb is indeed PNAG-dependent. 
Interestingly, depending on the S. epidermidis strain used, the presence of mAb F598 had a differential 
effect on biofilm accumulation. In the case of the strain RP62A we observed a 42% reduction in biofilm 
biomass at the highest mAb concentration tested, while in the clinical strains 1457 and M184 the mAb 
F598 presented a doses-dependent increase of the biofilm accumulation of 300% and 333%, 
respectively. As observed in other studies that have used antibodies specific for S. epidermidis surface 
molecules, the observed enhancement of biofilm formation could be a result of increased PNAG 
expression caused by the early blockage of the polysaccharide [8]. On the other hand, monoclonal 
antibodies are highly specific and recognize only one particular epitope on the antigen, being, hence 
highly susceptible to small variations in the antigen. The specificity of mAb F598 for epitopes on PNAG 
that do not require the N-acetyl groups on the glucosamine monomers may have therefore contributed 
to the differential effects observed in biofilm accumulation. These would thus depend on the level of 
PNAG acetylation of individual strains, ultimately, controlled by the IcaB extracellular deacetylase [27], 
which was not addressed in this study. Therefore, mAbs directed to other epitopes of the PNAG might be 
better suited for inhibition of in vitro biofilm accumulation. A recent study reported that the blockage of 
S. epidermidis surface protein, Aap, by mAbs with specificity for different epitopes of the protein 
presented differential effect on biofilm accumulation in vitro: some of the mAbs decrease accumulation 
while others resulted in a biofilm accumulation enhancement [8].  
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Figure 5.3. Effect of mAb F598 specific to PNAG on S. epidermidis biofilm accumulation in vitro. The bars 
represent the median with interquartil range of two independent experiments with quadruplicates for each 
concentration tested. Statistical significance was analyzed one-way ANOVA test and Dunn’s multiple comparisons 
test with a 95% confidence level. *p<0.05, ** p<0.01 vs. 0 (TSB). NRS-normal rabbit serum; OD-optical density. 
 
This result suggest a difference between the reported effect of mAb F598 against PNAG-producing 
bacteria in animal models [12,15], and its efficiency at inhibiting in vitro static biofilm accumulation 
among different S. epidermidis strains. While the stimulation of biofilm formation by S. epidermidis 
grown in vitro may raise questions regarding the usage of mAb F598 in vivo, the results do not 
necessarily exclude that mAb F598 could be effective in vivo against biofilm infections. Notably, many 
biofilms are formed under flow conditions and it is not clear to what extent shear stress from flow over 
in vivo biofilms contributes to biofilm formation, and whether under those conditions the effect of mAb 
F598 might be different.  
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CONCLUSIONS 
Our findings have shown, in one hand, that normal rabbit serum present unknown factors that 
effectively inhibit S. epidermidis biofilm accumulation in vitro, which need to be  studied in detail in order 
to better understand S. epidermidis biofilm formation in vivo, and thus the role of the host factors in the 
establishment of the biofilm. On the other hand, the study involving the monoclonal antibody further 
stress the necessity to use more than a few strains to test the effect of such antibodies since in particular 
cases it may increase biofilm formation resulting in a deleterious effect.  
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CONCLUDING REMARKS 
Throughout this thesis the molecular interactions between S. epidermidis biofilms and the host immune 
system were addressed. Due to the high complexity of the host-pathogen interaction we focused our 
studies in key stages of the biofilm lifecycle, namely the interaction between mature biofilms or biofilm-
released cells with the host immune system.  
 
Our primary interest was to discover the genetic alterations achieved by S. epidermidis biofilms in the 
context of the host immune response. However, due to the known technical issues associated with RNA 
extraction from Gram-positive bacteria and biofilm samples, several RNA extraction kits were tested. It 
was concluded that the most efficient RNA extraction kits for S. epidermidis biofilms were the ones 
with mechanical- and chemical-based lysis, yielding RNA with highest quality of all. Interestingly, we 
also found that different cDNA synthesis kits could strongly impact the outcome of gene expression 
analysis in S. epidermidis biofilms. Furthermore, we have devised a custom made qPCR reaction that 
was able to achieve the high standards required for this kind of analysis, however reducing the final 
volumes of cDNA or qPCR reaction, which allowed us to save considerable amounts of money.  
 
Having an efficient gene expression quantification workflow completely optimized, we then proceeded 
to the characterization of the transcriptomic alterations in S. epidermidis biofilms upon exposure to 
human blood. It was observed that S. epidermidis biofilms were able to withstand the high bactericidal 
activity of human blood, which was probably due to the extensive changes observed in its 
transcriptome. One of the most important and striking observations was the great increase in the 
expression of iron uptake systems, which suggests this as an important mechanism for evasion and 
survival from the human blood-circulating immune effectors.  
 
We were also interested in studying the final stage of the biofilm lifecycle. Biofilm disassembly, and thus 
biofilm-released cells, has been associated with the development of several acute infections. 
Nevertheless, the virulence potential of these cells remained to be addressed. Hence, S. epidermidis 
biofilm-released cells were characterized with reference to several different potential virulence factors. 
Interestingly, despite earlier suggestions that biofilm-released cells would quickly revert to their 
planktonic phenotype, it was observed that in the case of S. epidermidis, biofilm-released cells 
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presented a particular phenotype displaying, simultaneously, features of both planktonic and biofilm 
cells. These differences had an impact in S. epidermidis virulence potential. The most remarkable 
feature of the S. epidermidis biofilm-released cells was their high capability to withstand the action of 
tetracycline. This resistance may have important consequences in the efficacy of prophylactic and 
therapeutic measures based in antibiotics that act in protein synthesis blockage. Nevertheless, this issue 
needs to be investigated in more detail. 
 
Finally, we tested whether a monoclonal antibody raised against PNAG could be used as a therapeutic 
approach against S. epidermidis biofilm accumulation, since this has been considered one of the most 
promising strategies against biofilm formation by several microorganisms. Interestingly, we found out 
that due to the strain-to-strain variability, the tested antibody presented variable effects, sometimes 
resulting in an enhancement of biofilm accumulation.  
 
 
FUTURE PERSPECTIVES 
The work described in this thesis has provided valuable information on how S. epidermidis biofilms 
interact with the host immune system. Nevertheless it has also raised some important questions that 
need to be answered. Some of the suggestions that should be taken into consideration for future 
investigations are:  
1) Transcriptomic analysis of S. epidermidis biofilm-released cells upon exposure to human blood; 
2) The identification of the blood-circulating immune cells and soluble factors that induce 
transcriptomic changes in S. epidermidis biofilms and in its released cells; 
3)  Construction of mutants to identify the genes that are essential for survival and evasion of S. 
epidermidis biofilms and of its released cells. 
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